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ABSTRACT 
This thesis reports studies in three separate contexts that show how responsiveness can be 
introduced or tuned in different molecular systems thus providing desirable control over material 
properties.  
In Chapter 2, we designed a new quadruple hydrogen-bonding module (eDAN). The binding 
affinity of this molecule towards its partner (DeUG) was specifically controlled by redox 
reactions without affecting other hydrogen-bonding recognition pairs in the system. This 
orthogonal switch was successfully applied to tune supramolecular polymer blends (Scheme 0.1).  
In Chapter 3, we developed a scalable and general synthetic approach to solubilize and 
stabilize different classes of organic fluorophores, which may be useful in bioimaging. The 
crosslinked dendronized polymeric structure obtained by ring opening metathesis polymerization 
and intra-molecular ring close metathesis reduced the responsiveness of dyes toward reactive 
excited species (Scheme 0.2). 
In Chapter 4, we designed the first synthetic photoresponsive proton gate incorporated in a 
lipid layer. The new proton carrier features a boronic acid head-group for proton transfer, a stiff 
stilbene body for photoresponsiveness, and an alkyl tail for lipid incorporation. The light-induced 
cross-membrane proton transfer was quantified by the activity of an O2 reduction catalyst buried 
under the lipid layer by electrochemistry. This molecular switch mimics the natural system 
allowing precise control of proton relocation without perturbing the proton thermodynamics 
(Scheme 0.3).  
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Scheme 0.1 Molecular structures of the redox responsive hydrogen-bonding unit 
 
Scheme 0.2 Illustration of crosslinked dendronized polyols for dye encapsulation and 
stabilization 
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Scheme 0.3 Illustration of photoresponsive transmembrane proton transfer  
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Chapter 1 
Introduction 
 
This chapter provides a short introduction to the three separate projects described herein. Part of 
this chapter has been adapted from the following publications: 
Ying Li, Taiho Park, J. Kwansima Quansah, and Steven C. Zimmerman*, Synthesis of a Redox-
Responsive Quadruple Hydrogen-Bonding Unit for Applications in Supramolecular Chemistry, 
J. Am. Chem. Soc. 2011, 133, 17118–17121. 
 
Ying Li, Yugang Bai, Nan Zheng, Yang Liu, Gretchen A. Vincil, Benjamin J. Pedretti, Jianjun 
Cheng, and Steven C. Zimmerman*, Crosslinked Dendronized polyglyols as a General Approach 
for Brighter and More Stable Fluorophores, Chem. Commun., 2016, 52, 3781–3784. 
 
Ying Li, Edmund C. M. Tse, Christopher J. Barile, Andrew A. Gewirth* and Steven C. 
Zimmerman*, Photoresponsive Molecular Switch for Regulating Transmembrane Proton-
Transfer Kinetics, J. Am. Chem. Soc. 2015, 137, 14059–14062. 
 
Christopher J. Barile, Edmund C. M. Tse, Ying Li, Thomas B. Sobyra, Steven C. Zimmerman, 
Ali Hosseini, and Andrew A. Gewirth*, Proton Switch for Modulating Oxygen Reduction by a 
Copper Electrocatalyst Embedded in a Hybrid Bilayer Membrane, Nat. Mater. 2014, 13, 619–
623. 
  
1.1 Hydrogen-Bonding Units and Supramolecular Chemistry  
Hydrogen bonding is a non-covalent interaction that occurs between certain functional 
groups on different molecules or between different parts of a single molecule.1 This electrostatic 
dipole-dipole interaction is ubiquitous in nature and essential to life. When a hydrogen atom is 
affected by a nearby electronegative atom or environment, it can serve as a hydrogen-bond donor. 
A hydrogen-bond acceptor is usually an electronegative atom such as fluorine, oxygen or 
nitrogen. For example, hydrogen bonding exists between the hydrogen atom of one water 
molecule and the oxygen atom of an adjacent water molecule. Despite the fact that hydrogen 
bonds are not as strong as covalent bonds, these two types of bonds have some common features. 
The most important characteristic is that they are both directional so that a hydrogen bonding 
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donor molecule can only interact with a limited number of hydrogen bonding acceptors.1-3 This 
property gives rise to the selectivity and specificity of hydrogen bonds and plays an essential role 
in determining three-dimensional structures adopted by biomacromolecules. DNA base-pairs 
elegantly showcase the importance of hydrogen bonds with the specific pairing of guanine to 
cytosine and adenine to thymine. This is one of the driving forces for the double-helical structure 
of DNA.4  
Scheme 1.1 Representative quadruple hydrogen-bonding pairs, the corresponding binding 
patterns and affinity measurement 
 
 To mimic the function of base-pairs, different heteroaromatic molecules featuring arrays of 
hydrogen-bond donor and acceptor groups have been designed and synthesized. In principle, the 
binding affinity could increase infinitely with the increasing number of hydrogen-bond 
donor/acceptor pairs. To achieve an appreciable binding affinity with compact molecular 
structures, quadruple hydrogen-bonding units represent a desirable approach.5-8 Scheme 1.1 lists 
some examples of quadruple hydrogen-bonding pairs with their binding pattern and stability 
indicated. Although these modules all contain four arrays of hydrogen bonding, their association 
constants covers a wide range, Kassoc = 104 to 1012 M−1. This large difference comes from the 
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specific pattern of the hydrogen-bonding arrays, where attractive interactions reinforce stability 
but repulsive interactions weaken binding.8-10  
Hydrogen-bonding modules have been widely applied in supramolecular chemistry because 
of their directional binding and potential for strong binding.11-17 In the context of specific 
functional materials and devices, high binding constants are not always a virtue, particularly 
when scalability and stability come into consideration. Indeed, 2-ureido-4[1H]-pyrimidinone 
(UPy) has been extensively used in the self-assembly of small molecules, macromolecules, 
molecules on surfaces and even inorganic materials although its binding constant is not one of 
the highest reported.18 In addition, hydrogen bond strength can be affected by perturbations in 
temperature, solvent polarity and solution pH.1,19-20 This responsiveness allows further control 
over the functional materials to adopt changes on demand. However, the external stimuli 
mentioned above often cannot target a specific type of hydrogen-bonding pairs.  
1.2 The Development of Brighter and More Stable Fluorophores 
Organic fluorophores are chemicals capable of absorbing photons of certain energy and re-
emitting photons of different energy.21 Usually the emitted photons are of lower energy when 
compared with input photons because of energy loss. This unique optical property has allowed 
fluorophores to be widely applied in biological studies.22-23 Figure 1 arranges a variety of 
fluorophores according to their brightness against the corresponding wavelength of maximum 
absorption.24 A fluorophore’s brightness is defined as the product of the extinction coefficient at 
the excitation wavelength (ε at λex) and the quantum yield (Φ). According to this diagram, many 
fluorophores are extended conjugated systems that have limited solubility in aqueous solutions 
by themselves. Aqueous solubility would be necessary for a fluorophore to be utilized in 
biological studies because almost all the biological processes happen in an aqueous environment. 
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In general, installing charged functional groups25 or aqueous soluble macromolecules26-29 can 
readily solve the solubility issue.  
 
Figure 1.1 Plot of fluorophore brightness (ε×Φ) vs the wavelength of maximum absorption (λmax) 
for the major classes of fluorophores. The color of the structure indicates its wavelength of 
maximum emission (λem). For clarity, only the fluorophoric moiety of some molecules is shown. 
Copyright 2008 ACS chemical biology. 
However, fluorophores are prone to quenching, which can lead to either a reversible or 
irreversible decrease in fluorescence intensity. Irreversible loss of fluorescence is called 
photobleaching. Reversible quenching stems from noncovalent interactions, such as complex 
formation, collisional quenching and energy transfer.30-32 In contrast, cleaving or forming 
covalent bonds induce irreversible quenching.33-34 At high fluorophore concentrations, 
fluorescence intensity may drop significantly as a result of intermolecular interactions and 
chemical reactions between ground state or excited dye molecules. At low dye concentrations, 
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reactions between excited dyes and excited surrounding molecules, such as oxygen, dominate the 
photobleaching processes.35 
To track or analyze biological processes more effectively and precisely, tremendous efforts 
have been invested in developing brighter and more stable fluorophores. Different methods have 
been explored to enhance fluorophore optical properties and to reduce the responsiveness of dyes 
toward reactive species. These efforts can be mainly classified into five categories: 1) new 
fluorophore structures36-37; 2) small-molecule additives38-39; 3) small-molecule conjugation40; 4) 
noncovalent encapsulation41 and 5) macromolecule conjugation42.  
1.3 Proton-Coupled Electron Transfer and Transmembrane Proton-Transfer  
Proton-Coupled Electron Transfer (PCET) is ubiquitous in nature43, essential to life44 but 
particularly difficult to study because of the complexity of natural systems.45 The terminal step 
of the respiratory redox chain involves an oxygen reduction reaction (ORR) catalyzed by 
cytochrome c oxidase (CcO) with the participation of 4 electrons (e−) and 4 protons (H+).46 This 
ORR is proposed to be the prerequisite for building up a substantial proton gradient across cell 
membranes and thus facilitate ATP synthesis.47 The reaction center contains multiple metal 
complexes and the reaction pathways depend on the thermodynamics and kinetics of electrons 
and protons available. CcO-inspired scaffolds have provided a model platform to decipher the 
PCET mechanisms.48-49 Collman and Chidsey et al. designed a structural and functional analog 
of the CcO active site that allows precise control of electron flux.50 For the first time, the kinetics 
of electron transfer was delineated from the thermodynamics and suggested to be crucial for 
ORR selectivity. We recently developed a new experimental framework to permit fine-tuning of 
proton-transfer kinetics without perturbing the thermodynamics.51-52 The regulation took 
advantage of the “flip-flop” diffusion of proton carriers inside lipid membranes. Unfortunately, 
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the diffusion happens spontaneously and a more precise control would be beneficial. A solution 
to that problem is presented herein. 
1.4 Terms and Abbreviations 
Grubbs 1st generation catalyst: Benzylidene-bis(tricyclohexylphosphine)dichlororuthenium, 
also named as bis(tricyclohexylphosphine)benzylidine ruthenium(IV) dichloride, CAS No. 
172222-30-9. 
Grubbs 2nd generation catalyst: (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)-
dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium, CAS No. 246047-72-3. 
Pyridine-modified Grubbs 2nd generation catalyst, also referred as Grubbs 3rd generation 
catalyst: Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene](benzylidene)bis(pyri-
dine)ruthenium(II), synthesized from Grubbs 2nd generation catalyst and pyridine. 
ROMP: Ring-opening metathesis polymerization. 
RCM: Ring-closing metathesis. 
PGD: Polyglycerol dendron. 
EDC: N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide, peptide coupling reagent, CAS No. 
1892-57-5. Its hydrochloride salt (EDC·HCl, CAS No.	  25952-53-8) is usually employed. 
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Chapter 2 
Synthesis of a Redox-Responsive Quadruple Hydrogen-Bonding Unit for 
Applications in Supramolecular Chemistry 
 
Part of this chapter is adapted from the following publication: 
Ying Li, Taiho Park, J. Kwansima Quansah, and Steven C. Zimmerman*, Synthesis of a Redox-
Responsive Quadruple Hydrogen-Bonding Unit for Applications in Supramolecular Chemistry, 
J. Am. Chem. Soc. 2011, 133, 17118 - 17121. 
  
2.1 Introduction  
Supramolecular building blocks featuring arrays of hydrogen-bond donor and acceptor 
groups have played a key role in self-assembled systems, nanofabrication, and supramolecular 
polymer chemistry.1-7 One advantage of the supramolecular approach is that it allows for the 
development of stimuli-responsive or smart systems and devices. For example, the hydrogen-
bond complexation strength is sensitive to pH, temperature, and solvent polarity.8-12 Indeed, 
Leigh and co-workers showed that by protonating 2,6-diaminopyridine, a unit with a DAD 
hydrogen-bonding array (D = donor, A = acceptor) was converted into a DDD unit, thereby 
increasing its affinity for an AAA unit by >109-fold.13-14 Smith recently defined a good switch as 
one in which the external signal changes the association constant (Kassoc) by at least 10-fold.15-16 
By this measure, the Leigh system was remarkable, equivalent to an on−off switch. Furthermore, 
it highlighted the general utility of altering the hydrogen-bonding motif in developing effective 
stimuli-responsive units. However, external stimuli such as changes in pH, temperature, and 
solvent polarity often lack the necessary selectivity when more than one hydrogen-bonded 
complex is involved, making switching difficult to achieve in a practical setting.  
Photo- and electrochemical approaches have distinct advantages because often they are 
reversible and efficient, and these methods avoid the addition of chemical reagents. Apart from 
Hecht’s photo-switchable triple hydrogen-bonding motif,17 considerable effort has focused on 
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electroactive units.15-16, 18 Rotello19-21 has pioneered a particularly useful redox approach 
involving the reduction of recognition units with imide-like groups. The reduction does not alter 
the hydrogen-bonding motif but rather converts the ADA array of hydrogen-bond donor and 
acceptor groups into the corresponding radical anion (ADA−), which pairs more strongly with its 
complementary (DAD) partner.  
Herein we report an approach that uses a redox reaction to transform the DAAD hydrogen-
bonding array in 1red to a DAA (or DAAA) array in 1ox, which leads to a surprisingly large 
change in hydrogen-bonding complexation strength (Scheme 2.1). Compound 1 (1red or 1ox), 
designated as eDAN, is based on our previously reported 2,7-diamido-1,8-naphthyridine (DAN) 
unit that forms a very stable22 and high-fidelity23 quadruply hydrogen-bonded complex with the 
ureas of guanosine (UG)24 and deazaguanosine  2 (DeUG).25 The DeUG unit is a more stable and 
preparatively scalable analogue of UG. We further report that the eDAN redox switch can be 
applied to supramolecular hydrogen-bonded polymer blends.26-28  
Scheme 2.1 Interconversion of 1red and 1ox and the structure of 2  
 
2.2 The Development of Redox-Responsive Hydrogen-Bonding Unit 
The three-step synthesis of 1red from commercially available 3 is outlined in Scheme 2.2. 
Compound 5 was recently reported as a substrate for copper-catalyzed amination.29 However, 
neither Cu2O nor various palladium catalysts effected the C−N bond formation between 5 and 4-
aminophenol. Ultimately, it was found that this amination reaction takes place directly using 
pyridine in dioxane at high temperature (see details in 2.6 Experimental). 
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Scheme 2.2 Synthesis of 1red  
 
 
Figure 2.1 Cyclic voltammetry of eDAN (1mM) in Bu4NPF6 (0.1 M) CH2Cl2 solution at a scan 
rate of 100 mV/s with Pt mesh as the counter electrode, Pt wire as the working electrode, and 
Ag/AgCl as the reference electrode. 
The interconversion of 1red and 1ox was examined both chemically and electrochemically. 
Cyclic voltammetry indicated that the oxidation of 1 was not fully reversible (Figure 2.1). The 
redox half-reactions could be accomplished chemically and on a preparative scale by treatment 
of 1red with activated MnO2.30 The reduction back to 1red occurred with zinc/acetic acid 
(Zn/H+).31 With an eye toward applications and specifically an interest in materials that might 
respond to oxygen, a broader set of redox reagents was examined. As shown in Table 2.1, 
copper(II) acetate and N,N’-bis(salicylidene)ethylene-diaminocobalt(II) (salcomine)32 serve as 
N N
H
H2N O Pyridine, 100 oC,
70%
Cl
O
N N
H
N
H
O
O
PBr3
110 oC, 56%
N NN
H
Br
O
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100 oC, 82%
H2N OH 1red
3 4
5
+
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catalysts for the oxidation of 1red by O2. However, in the presence of 2, only salcomine effected 
the conversion of 1red to 1ox, with 0.1 equiv. required to reach ca. 80% conversion. The resistance 
to oxidation in the presence of 2 can be attributed to the high stability of the 1red⋅2 complex and 
the low solubility of Cu(OAc)2 in chloroform. The reduction of 1ox was effected by 
hydroquinone in 96% yield efficiently. The progression of this reaction was monitored by UV-
visible spectrophotometry as shown in Figure 2.2. 
Table 2.1 Redox chemistry of 1a 
 
       entry redox agent   equiv temp. (°C) time (min) yield (%)b 
       Ox-1 activated MnO2 5    25   30 89 
       Ox-2  Cu(OAc)2/O2        0.2    50 720 82 
       Ox-3  salcomine/O2        0.05 25   30 92 
Red-1  Zn/Acetic acid        2/20 25   30 80 
Red-2  hydroquinone 1 25   30 96 
aReactions were performed in chloroform. bIsolated yields. 
To explore the limit of the reversibility of this chemical redox approach, multicycle redox 
chemistry was carried out (see details in 2.6 Experimental). According to the overlay of the 
truncated 1H NMR spectra (Figure 2.3), the proton signal centered at about 8.65 ppm, 
corresponding to 1ox, did show up in an alternating fashion. As a result, the multicycle chemical 
redox of 1 could be achieved but with the accumulation of side products over time. 
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Figure 2.2 UV-visible spectra of 1ox·2 (3 × 10-5 M: 3 × 10-5 M) in chloroform reacting with ~1 
equiv. of hydroquinone over time. 
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`  
Figure 2.3 An overlay of the truncated 1H NMR spectra of small molecules undergoing 
multicycle redox chemistry. 
2.3 Binding Studies of Hydrogen-Bonding Modules 
The abilities of 1red and 1ox to complex 2 were examined qualitatively by 1H NMR 
spectroscopy (Figure 2.4). To avoid proton signal overlapping in the aromatic region, CD2Cl2 
was chosen as the NMR solvent. Worthy of note are the significant downshifts of the NHA and 
NHB protons of 2 upon addition of 1red. In contrast, the same protons shift minimally upon 
addition of 1ox. A competitive 1H NMR study with 1red competing for DeUG against DAN was 
performed to confirm the strong binding affinity between 1red and DeUG (Figure 2.5). The 
binding constant for DAN⋅DeUG hetero-complex measured by isothermal titration33 was 1.3 × 
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107 M-1, too high to measure accurately by direct 1H NMR titration study. Competitive 1H NMR 
studies in CDCl3 however show that 1red binds competitively with DeUG at the presence of 
DAN, indicating that the 1red⋅DeUG complex is as strong, if not stronger, than the DAN⋅DeUG 
complex (Figure 2.5). From the spectrum, the most downfield-shift signal moves downfield as 
the ratio of [1red]/[DAN] is increased, indicating 1red binds to DeUG with an affinity comparable 
to that of DAN. A similar study has been performed with 1red competing for DeUG against 
BDANNH2 (Figure 2.6). 
 
Figure 2.4 (a) 1H NMR spectra (500 MHz, CD2Cl2, 295 K) of (top) 1red, (middle) 1red⋅2, and 
(bottom) 2 showing the changes to 1red and 2 upon association to form 1red⋅2. (b) 1H NMR 
spectra (500 MHz, CD2Cl2, 295 K) of (top) 1ox, (middle) 1ox⋅2, and (bottom) 2. The assignments 
in (a) and (b) are tentative. The 1red⋅2 complex may form two ways, both likely in fast exchange. 
Some peaks are cut off.  
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Figure 2.5 Competitive 1H NMR spectrum of 1red competing for DeUG against DAN ([DeUG] = 
3.9 mM in CDCl3). 
 
Figure 2.6 Competitive 1H NMR spectrum of BDANNH2 competing for DeUG against DAN 
([DeUG] = 3.9 mM in CDCl3). 
The titration of 1red with 2 and 1ox with 2 were followed by UV-visible spectroscopy 
respectively (Figure 2.7 and 2.8). As the concentration of 2 increases, the absorption of the 
mixture 1red and 2 kept shifting. The overlay of the spectra showed a couple quasi-isosbestic 
points. Furthermore, the absorption of the mixture 1ox and 2 barely changed as more 2 was added, 
which suggests no detectable binding affinity for 1ox⋅2. In addition, the Job plot for the 
complexation of 1red⋅2 indicated a 1:1 complex stoichiometry (Figure 2.9).  
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Figure 2.7 UV-Vis spectra of 1red (3 × 10-6 M) upon addition of 2 (0-8 eq). 
 
Figure 2.8 UV-Vis spectra of 1ox (3 × 10-6 M) upon addition of 2 (0-4 eq).  
Wavelength (nm)
A
bs
.
0.5
0.4
0.2
0.0
250 300 350 400 450 500   
Wavelength (nm)
A
bs
.
0.3
0.2
0.1
0.0
250 300 400 500 600   
	  
	  
20	  
 
Figure 2.9 Job plot for complexation of 1red⋅2. 
Quantitative complexation studies were performed with 1 and 2 in chloroform using 
isothermal titration calorimetry (ITC) (Figure 2.10, see details in 2.6 Experimental). The 1red⋅2 
complex exhibited an apparent association constant (Kassoc) of 1.1 × 106 M−1. After correction for 
the weak dimerization of 2, which causes the endothermal dip leading up to 1 equiv in the ITC 
curve, the actual value of Kassoc was found to be 1.4 × 106 M−1.25 
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Figure 2.10 ITC data for (a) 1red⋅2 and (b) 1ox⋅2.  
A series of ITC experiments were performed to further validate the binding study results. 
Figure 2.11a and 2.11b showed the detailed curve-fitting data for 1red⋅2 binding study at the 
concentration of [1red] = 3.27 mM and [2] = 0.323 mM. Figure 2.11c showed a similar binding 
study for 1red⋅2 at a lower concentration: [1red] = 1.635 mM and [2] = 0.1615 mM. The 
endothermic dip becomes less obvious at lower concentrations. However, the curve fitting results 
consistently gave Kassoc > 10 6 M−1 regardless of the different concentrations used or data points 
applied for curve fitting. Figure 2.11d showed the titration curve for BDANNH2⋅2 at a high 
concentration: [BDANNH2] = 3.27 mM and [2] = 0.323 mM. Apart from the mild endothermic 
dip, the binding affinity between BDANNH2 and 2 is close to that between 1red and 2. Taking 
together all the ITC data, the large value of Kassoc for 1red⋅2 is similar to that reported for the 
DAN⋅UG and DAN⋅DeUG complexes. The data are consistent with a 1:1 complex for 1red·2 with 
an apparent Kassoc (1red ·2) = 1.2 × 106 M-1.  
C dx.doi.org/10.1021/ja2069278 |J. Am. Chem. Soc. XXXX, XXX, 000–000
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information: PS-DAN (5) Mn = 18.5 kDa, PDI = 1.41; PBMA-
DeUG (6) Mn = 24 kDa, PDI = 1.23. Details of the polymer
synthesis and characterization can be found in the SI.
Switching experiments were performed by dissolving PS-DAN
5 and PBMA-DeUG 6 in chloroform at a concentration of
30 g/dL. Upon addition of the solution of 6, the clear, free-
ﬂowing solution of 5 became a viscous gel (Figure 3a). Upon
addition of 1red (ca. 100 equiv per DeUG unit), the gel was
destroyed (Figure 3b). After treatmentwith salcomine (<0.5 equiv
with respect to 1red) and bubbling of O2 through the solution for
5 min, the gel was restored (Figure 3c). Finally, the reformed gel
was treated with hydroquinone (1 equiv per eDAN 1), leading to
a solution (Figure 3d). Each step was followed by 1H NMR
spectroscopy, and control experiments were performed to conﬁrm
that the redox reagents were responsible for the 1red to 1ox inter-
conversion and that this in turn controlled the formation of the
supramolecular polymer blend.14 Multiple cycles were not exam-
ined, but in 1H NMR experiments with 1 alone, several redox
cycles were possible, although obvious byproducts were formed.14
In conclusion, the redox-responsive eDAN module 1 was
designed and shown to pair with high aﬃnity to DeUG in its
reduced form (!ΔG! = 8.3 kcal mol!1 for 1red 3 2) but to bind
weakly when oxidized (!ΔG! = 3.8 kcal mol!1 for 1ox 3 2). The
very large decrease in binding points to the utility of coupling
the stimulus and the hydrogen-bonding motif displayed by the
recognition unit. A simple application to stimuli-responsive
supramolecular polymer networks that did not require incor-
poration of the responsive unit into the polymers was demon-
strated. Future improvements will involve altering the naphthy-
ridine unit in a way that allows reversible electrochemical
switching.
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Scheme 3. Synthesis of Reactive Monomers and Copolym-
erization To Give (a) PS-DAN (5) and (b) PBMA-DeUG (6)a
aAbbreviations: AIBN, azobis(isobutyronitrile); DMAP, 2,6-dimethyla-
minopyridine; EDCI, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Figure 3. 14(a) Blend of PS-DAN and PBMA-DeUG. (b) Blend with
1red added. (c) Reformation of viscous gel by oxidation of 1red to 1ox.
(d) Redestruction of the polymer blend by reduction of 1ox to 1red.
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Figure 2.11 (a) ITC data for DeUG titrated with 1red (part of the data points were removed to 
show that the endothermic dip minimally affected the Ka value and that the error range is 
acceptable); (b) full data set for DeUG titrated with 1red. (c) ITC data for DeUG titrated with 1red 
at lower concentration. The dip becomes less obvious due to the dimerization of DeUG 2. 
Lowering the concentration to 0.654 and 0.0646 mM resulted in ITC plots with considerably 
more scatter. However, the Kassoc value remained at ca. 106 M-1 regardless of the concentration 
used. (d) ITC data for DeUG titrated with BDANNH2, giving similar Kassoc compared with 1red·2. 
The titration curve also shows an endothermic dip.  
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Figure 2.12 ITC data for DeUG titrated with 1ox (a one binding site model gave N = 2.38, 
indicating the given Ka was not reliable). 
 
Figure 2.13 Curve fitting of 1H NMR titration of 2 (1 mM) with 1ox. 
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Although the ITC data for 1ox⋅2 did not allow the binding to be quantified (Figure 2.12), a 1H 
NMR titration study afforded a corrected Kassoc of 6.7 × 102 M−1 for 1ox⋅2 (Figure 2.13). The 
curve obtained from the 1H NMR titration study was fit to Equation (1). We believe the chemical 
shift of proton B represents the binding strength better than D, which is a bit further away from 
the hydrogen-bonding array. As a result, Kapp = 4.5 × 102 M-1. The binding constant was further 
corrected using Equation (2). 
y = δmax −δ0( )2 × x +1+
1
Ka ×0.001− x +1+ 1Ka ×0.001
#
$
%
&
'
(
2 − 4x
#
$
%
%
%
%
%
&
'
(
(
(
(
(
                                         (1) 
K2 = Kapp 1+ 2K1[2]( )                                                                                      (2) 
Equation 2 was derived as follows33: 
1ox + 2 K2← →# 1ox ⋅2
2+ 2 K1← →# 2 ⋅2
K2 =
[1ox ⋅2]
[1ox ][2]
=
[1ox ⋅2]
1oxtotal −[1ox ⋅2]( ) 2total −[1ox ⋅2]− 2[2 ⋅2]( )
K1 =
[2 ⋅2]
[2]2
Kapp =
[1ox ⋅2]
1oxtotal −[1ox ⋅2]( ) 2total −[1ox ⋅2]( )
K2
Kapp
=
2total −[1ox ⋅2]
2total −[1ox ⋅2]− 2[2 ⋅2]
=
[2]+ 2[2 ⋅2]
[2] =1+ 2K1[2]
 
The more than 2 × 103-fold decrease in Kassoc represents one of the largest attenuations of 
binding strength for a redox switch. Indeed, the nearly 5 kcal mol−1 loss of binding affinity is too 
large to be attributed to the loss of a single hydrogen bond. Similar DAA⋅ADD complexes show 
Kassoc values of ca. 104 M−1.22 Two factors may readily account for the weaker binding by 1ox. 
First, simple modeling indicates that 1ox prefers the conformer shown in Figure 2.10b, in which 
the azaquinone unit sterically blocks the DAA hydrogen-bonding edge. The complexation may 
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occur as shown in the 1ox⋅2 complex in Figure 2.4b (DAAA array), but it contains two flanking 
nonbonded electron pairs (a destabilizing interaction) and uses a less stable conformer.  
2.4 Applications in Supramolecular Chemistry 
We previously reported that polystyrene (PS) and poly(butyl methacrylate) (PBMA), two 
ordinarily immiscible polymers, form miscible blends/gels when the PS and PBMA contain 
DAN and UG units, respectively, at compositions of a few mole percent.26-28 The ability of free 
DAN to inhibit this supramolecular polymer blend suggested the use of eDAN 1 to create 
stimuli-responsive systems. PS-DAN (5) was synthesized in three steps, including a free radical 
polymerization as described previously, except with the small but significant change that the 
synthesis began with 2-ethylhexylamido-containing DAN 4 (Scheme 2.3a). In comparison with 
the previous approach26-28, the incorporation of the branched alkyl chain greatly improved the 
yield of each step in Scheme 2.3 perhaps because of its increased resistance to cleavage and 
improved solubility in organic solvents.34  
Scheme 2.3 Synthesis of Reactive Monomers and Copolymerization to Give (a) PS-DAN (9) and 
(b) PBMA-DeUG (14)a  
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Scheme 2.3 (cont.) 
 
a Abbreviations: AIBN, azobisisobutyronitrile; DMAP, 2,6-dimethylaminopyridine; EDCI, 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide.  
PBMA-DeUG (14) was synthesized analogously to the previously described12 UG-containing 
PBMA (Scheme 2.3b). Shorter linkages between the DeUG unit and the polymer backbone were 
examined but led to opaque, viscous polymer solutions upon mixing with PS-DAN (9) in 
chloroform, indicating phase separation. Both of the polymers were characterized by size-
exclusion chromatography (SEC) and 1H NMR spectroscopy, the latter indicating that the 
degrees of recognition-unit incorporation were 6 and 4 mol% for 9 and 14, respectively. The 
SEC instrument was equipped with a UV detector, which confirmed the attachment of DAN and 
DeUG and gave the following polymer information: 9 Mn = 18.5 kDa, PDI = 1.41; 14 Mn = 24 
kDa, PDI = 1.23. Details of the polymer synthesis and characterization can be found in Section 
2.6 Experimental.  
Switching experiments were performed by dissolving PS-DAN 9 and PBMA-DeUG 14 in 
chloroform at a concentration of 30 g/dL. Upon addition of the solution of 14, the clear, free- 
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flowing solution of 9 became a viscous gel (Figure 2.14a). Upon addition of 1red (ca. 100 equiv 
per DeUG unit), the gel was destroyed (Figure 2.14b). After treatment with salcomine (<0.5 
equiv with respect to 1red) and bubbling of O2 through the solution for 5 min, the gel was 
restored (Figure 2.14c). Finally, the reformed gel was treated with hydroquinone (1 equiv per 
eDAN 1), leading to a solution (Figure 2.14d). Each step was followed by 1H NMR spectroscopy 
to support the notion that the redox of 1 was successfully applied to tune the supramolecular 
polymer blends (Figure 2.15 and 2.16). 
 
Figure 2.14 (a) Blend of PS-DAN 9 and PBMA-DeUG 14. (b) Blend with 1red added. (c) 
Reformation of viscous gel by oxidation of 1red to 1ox. (d) Redestruction of the polymer blend by 
reduction of 1ox to 1red.  
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Figure 2.15 1H NMR spectrum of polymer blends of PS-DAN 9 and PBMA-DeUG 14 after 
oxidation of 1red to 1ox with salcomine and O2. 
	  
	  
Figure 2.16 1H NMR spectrum of polymer blends of PS-DAN 9 and PBMA-DeUG 14 after 
reduction of 1ox to 1red with hydroquinone. 
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To demonstrate that the sol-gel transition of PS-DAN 9 and PBMA-DeUG 14 described 
above was really caused by the redox chemistry of 1, control experiments were performed to rule 
out other possibilities. Figure 2.17a showed that if DAN instead of 1red was added into the 
polymer blend, no reformation of the gel could be achieved after salcomine/O2 treatment. In 
Figure 2.17b, if BBr instead of DAN was added to the polymer blend, no sol formation was 
observed nor after salcomine/O2 treatment. Lastly, the addition of hydroquinone to PS-DAN 9 
and PBMA-DeUG 14 ruled out the possibility that the redestruction of the polymer blend was 
caused by the polarity of hydroquinone (Figure 2.17c).  
	  
Figure 2.17 Control experiments for polymer blend study. 
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2.5 Conclusions 
In conclusion, the redox-responsive eDAN module 1 was designed and shown to pair with 
high affinity to DeUG in its reduced form (−ΔG° = 8.3 kcal mol−1 for 1red⋅2) but to bind weakly 
when oxidized (−ΔG° = 3.8 kcal mol−1 for 1ox⋅2). The very large decrease in binding underscores 
the utility of coupling the stimulus and the hydrogen-bonding motif displayed by the recognition 
unit. A simple application to stimuli-responsive supramolecular polymer networks that did not 
require incorporation of the responsive unit into the polymers was demonstrated. Future 
improvements will involve altering the naphthyridine unit in a way that allows reversible 
electrochemical switching.  
2.6 Experimental 
2.6.1 General Methods 
All reactions were carried out under a dry nitrogen atmosphere unless otherwise stated. 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) was purchased from 
Advanced ChemTech and used as received. All other chemicals were purchased from Sigma-
Aldrich and used without further purification unless otherwise indicated. Solvents were of 
reagent grade and used without further purification except as follows: Dry dichloromethane 
(DCM), N,N-dimethylformamide (DMF) and tetrahydrofuran (THF) were used directly from a  
solvent delivery system just prior to use. Freshly purchased triethylamine (TEA) and pyridine 
were dried and stored over 4Å molecular sieves. N-Butyl methacrylate and styrene were passed 
over aluminum oxide (activated, basic) prior to use. Reported reaction temperatures refer to the 
temperature of the heating medium. 
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Analytical thin-layer chromatography (TLC) was performed using 0.2 mm silica 60 coated, 
plastic plates with F254 indicator. Flash chromatography was performed using 230-400 mesh 
(40-63 µm) silica gel (SiO2) or 150 mesh, 58Å basic aluminum oxide.  
All NMR spectra were acquired in the VOICE laboratory, University of Illinois, Urbana-
Champaign with a Varian Unity 500 MHz instrument (1H, 500 MHz; 13C, 125 MHz) in CDCl3 
unless otherwise noted. Chemical shifts are in parts per million (ppm) and coupling constants (J) 
are in Hertz (Hz). For 1H spectra, chemical shifts are referenced to the residual proton solvent 
peak: 7.26 ppm for chloroform-d, 2.50 ppm for DMSO-d6. For 13C spectra, chemical shifts are 
referenced to the solvent peak at 77.5 ppm in chloroform-d and 39.5 ppm in DMSO-d6. 
Electrospray ionization mass spectrometry (ESI-MS) data were collected by the mass 
spectrometry service at the University of Illinois, Urbana-Champaign. Melting points were 
determined using a Thomas-Hoover melting point apparatus and are uncorrected. UV-visible 
spectroscopy data were recorded with a Shimadzu UV-2501PC spectrophotometer equipped with 
a temperature control unit set to 25 °C.  
Analytical size-exclusion chromatography (SEC) performed in THF (1.0 mL min-1, 30 °C) 
was accomplished using a Waters autosampler, pump, photodiode array and refractive index 
detector outfitted with Waters Styragel columns (HR5, HR4, HR3, HR1). Molecular weight was 
determined using conventional calibration against polystyrene standards. 
2.6.2 Synthetic Procedures 
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Compound 3, Compound 4, and Compound 5 were synthesized as previously reported.1 
Compound 1red. A mixture of 500 mg (1.43 mmol) of 5, 748 mg (6.86 mmol) of 4-aminophenol 
and 0.3 ml (3.72 mmol) of pyridine in 20 mL of 1 : 1 (v : v) dioxane:glyme was degassed by dry 
nitrogen for 20 min and heated to 100 °C for 24 h. The solvent was removed using a rotary 
evaporator. The crude was dissolved in 100 mL of CHCl3, washed three times with 80 mL of a 
sat. aqueous solution of NaHCO3 to remove most of the remaining 4-aminophenol. The organic 
layer was dried over anhydrous Na2SO4, gravity filtered, and concentrated using a rotary 
evaporator. The crude product was purified by gradient column chromatography (MeOH : DCM 
= 1 : 99 to 1 : 12) to give 432 mg (80%) of 1red  as a bright yellow solid: mp 118-120 ºC; 1H 
NMR δ 8.51 (s, 1H), 8.25 (d, J = 8.5, 2H), 7.92 (d, J = 8.5, 2H), 7.75 (d, J = 9, 2H,), 7.30 (d, J = 
8.5, 2H), 6.93 (d, J = 8.5, 2H,), 6.74 (d, J = 9.0, 2H), 2.20 (tt, J = 9 and 5, 1H), 1.76-1.64 (m, 2H), 
1.62-1.44 (m,2H), 1.36-1.20 (m, 4H), 0.926 (t, J = 7.5, 3H), 0.83 (t, J = 7, 3H); 13C NMR δ 175.8, 
158.6, 155.1, 154.1, 153.2, 139.1, 137.6, 131.1, 125.1, 116.6, 115.7, 111.2, 110.6 51.1, 32.5, 29.8, 
26.1, 22.8, 14.0 12.1; ESI-HRMS calcd for (C22H26N4O2·H)+ 379.2134, found 379.2144.  
 
Compound 1ox. 
Entry 1. To a 25 mL round bottom flask was added 23 mg (264 µmol) of activated MnO2, 20 mg 
(53 µmol) of 1red and 10 mL of CHCl3. The solution was stirred at room temperature for 30 min. 
MnO2 was filtered off and the organic portion was washed with a saturated aqueous solution of 
sodium ethylenediaminetetraacetic acid (EDTA⋅Na+), dried over anhydrous Na2SO4, gravity 
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filtered and concentrated using a rotary evaporator. Flash chromatography with a step gradient 
(MeOH : DCM = 1 : 99 to 1 : 12) afforded 17.7 mg (89%) of 1ox.  
Entry 2. To a 25 mL round bottom flask was added 2 mg (11 µmol) of copper(II) acetate and 10 
mL of CHCl3. The solution was heated to 50 ºC and a stream of O2 was bubbled through for 20 
min. In one portion was added, 20 mg (53 µmol) of 1red, and the mixture was heated for 12 h. 
The same workup as described for entry 1 afforded 17.4 mg (84%) of 1ox. 
Entry 3. To a 25 mL round bottom flask was added 0.9 mg (2.65 µmol) of salcomine and 10 mL 
of CHCl3. A stream of O2 was bubbled through for 20 min. In one portion was added, 20 mg (53 
µmol) of 1red, and the mixture was stirred for 12 h at room temperature. The same workup as 
described for entry 1 afforded 18.3 mg (92%) of 1ox. 
A bright red solid: mp 81-83 °C; 1H NMR δ 8.60 (d, J = 9, 1H), 8.52 (s, 1H), 8.22 (d, J = 9, 1H), 
8.21 (d, J = 8, 1H), 7.33 (dd, J = 9.5, 2.5, 1H), 7.30 (dd, J = 10.5, 2.5, 1H), 7.25 (d, J = 8.5, 1H), 
6.75 (dd, J = 10, 2, 1H), 6.55 (dd, J = 10, 2, 1H), 2.26 (tt, J = 9, 5, 1H), 1.80-1.67 (m, 2H), 1.66-
1.50 (m, 2H), 1.38-1.28 (m, 4H), 0.97 (t, J = 7.5, 3H), 0.88 (t, J = 7, 3H); 13C NMR δ 187.2, 
175.6, 163.2, 159.0, 154.3, 154.2, 141.4, 139.2, 138.5, 134.1, 134.0, 129.9, 118.6, 116.5, 114.8, 
51.0, 32.5, 29.8, 26.1, 22.8, 14.0 12.1; ESI-HRMS calcd for (C22H22N4O2·H)+ 377.1978, found 
377.1972. 
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Compound 61 and Compound 72 were synthesized as previously reported. 
Compound 8. A mixture of 1.12 g (35.2 mmol) of 7, 1.2 g (42.2 mmol) of 6 and 40 mg (2.7 
µmol) of DMAP in 40 mL of DCM was stirred at room temperature for 10 min. In one portion, 
866 mg (52.8 µmol) of EDCI was added and the mixture was stirred at room temperature 
overnight. The solution was washed with 30 mL of water and the water layer was extracted twice 
with 10 mL of DCM. The combined organic layers were washed with 30 mL saturated brine, 
dried over anhydrous Na2SO4, gravity filtered, and concentrated using a rotary evaporator. Flash 
chromatography with a step gradient (MeOH : DCM = 1 : 49 to 1 : 14) afforded 1.7 g (83%) of 8 
as a white waxy solid: mp 63-65 °C; 1H NMR δ 8.47 (d, J = 9, 1H), 8.43 (d, J = 9, 1H), 8.40 (br s, 
1H), 8.38 (br s, 1H), 8.20 (d, J = 8.5, 1H), 8.12 (d, J = 9, 1H), 7.39 (d, J = 8, 2H),  7.30 (d, J = 8, 
2H), 6.70 (dd, J = 18, 11, 1H), 5.74 (dd, J = 18, 1, 1H), 5.25 (tt, J = 11.5, 1, 1H), 5.09 (s, 2H), 
2.43 (t, J = 7.5, 2H), 2.33 (t, J = 7, 2H), 2.22 (m, 1H), 1.78-1.66 (m, 6H), 1.66-1.49 (m, 6H), 
1.38-1.26 (m, 8H), 0.96 (t, J = 7, 3H), 0.87 (t, J = 7, 3H); 13C NMR δ 175.7, 173.7, 154.2, 154.1, 
153.7, 139.1, 139.1, 137.6, 136.4, 135.7, 128.5, 126.4, 118.3, 114.4, 113.7, 113.7, 66.0, 50.8, 
37.9, 34.3, 32.4, 29.8, 29.2, 29.1, 29.1, 29.1, 26.0, 25.2, 25.0, 22.8, 14.0, 12.1; ESI-HRMS calcd 
for (C35H46N4O4·H)+ 587.3597, found 587.3592. 
Polymer 9. A mixture of 586 mg (1 mmol) of 8 and 3.4 mL (30 mmol) of styrene, passed 
through a column of dry basic aluminum oxide, in 20 mL of benzene was stirred at room 
temperature. A stream of argon (Ar) was bubbled through for 30 min. In one portion was added 
49.2 mg (0.3 mmol, 0.3 eq) of azobisisobutyronitrile (AIBN) and the mixture was stirred for 10 
min, sealed with a rubber septum and heated to 60 °C for 24 h. The polymerization was 
quenched by rapid freezing in liquid nitrogen and the solvent was removed using a rotary 
evaporator. The crude was dissolved in 2 mL of CHCl3 and precipitated into 200 mL of methanol. 
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The unreacted monomer 8 was soluble in methanol. The precipitated solid was collected by 
vacuum filtration. This process was repeated six times and the collected polymer was dried using 
a rotary evaporator. 1H NMR δ 8.52-8.42 (m, H in the naphthyridine), 8.15-8.06 (m, H in the 
naphthyridine), 7.26-6.86 (br m, Ar-H in styrene unit), 6.73-6.25 (br m, Ar-H in styrene unit), 
5.08-4.92 (br s, Ar-CH2O), 2.44 (br s, CH2), 2.33 (br s, CH2), 2.22 (br s, CH2), 2.14-1.18 (br s, H 
in styrene unit overlapped with CH2), 1.23-1.15 (m, CH2), 1.04-0.82 (m, CH3). 
 
Compound 103 was synthesized as previously reported.  
Compound 11. A mixture of 1 g (2.5 mmol) of 10 and 100 mg (0.8 mmol) of DMAP in 40 mL 
of ethylene glycol was stirred at room temperature for 10 min. In one portion was added 776 mg 
(5 mmol) of EDCI and the mixture was stirred at room temperature overnight. The solution was 
washed with 30 mL of water and the water layer was extracted twice with 10 mL of DCM. The 
combined organic layers were washed with 30 mL saturated brine, dried over anhydrous Na2SO4, 
gravity filtered, concentrated using a rotary evaporator and used in the following step without 
purification of chromatography. 
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Compound 12. A mixture of crude 11 (assumed 2.5 mmol), 1.17 g (1 mmol) of succinic acid 
and 100 mg (0.8 mmol) of DMAP in 40 mL of DCM was stirred at room temperature for 10 min. 
In one portion was added 776 mg (5 mmol) of EDCI was added. The mixture was stirred at room 
temperature overnight. The same workup as described for 11 was performed. Flash 
chromatography with a step gradient (MeOH : DCM = 1 : 49 to 1 : 9)  afforded 815 mg (60% 
over two steps) of 12 as a light pink solid: mp 147-149 °C; 1H NMR δ 11.26 (br s, 1H), 9.43 (br s, 
1H), 8.96 (br s, 1H), 6.88 (br s, 1H), 4.35 (s, 8H), 3.84 (d, J = 7.5, 2H), 3.80 (s, 2H), 3.42 (q, J = 
6, 2H), 2.69-2.57 (m, 4H), 1.78-1.52 (m, 8H), 1.51-1.41 (m, 2H), 1.23-1.07 (m, 3H), 1.03-0.89 
(m, 5H); 13C NMR δ 175.1, 172.2, 169.9, 159.7, 154.5, 148.6, 146.1, 127.8, 103.7, 102.4, 63.1, 
62.0, 52.1, 49.3, 49.2, 40.3, 39.0, 33.1, 32.1, 31.2, 29.4, 29.1, 28.9, 26.3, 25.9, 20.4, 14.0; ESI-
LRMS calcd for (C26H37N5O8·H)+ 548.6, found 548.3. 
Compound 13. A mixture of crude 12 (assumed 2.5 mmol), 280 mg (2.2 mmol) of 2-
hydroxyethyl methacry-late, and 100 mg (0.8 mmol) of DMAP in 30 mL of DCM was stirred at 
room temperature for 10 min. In one portion was added 776 mg (5 mmol, 2 eq) of EDCI and the 
mixture was stirred at room temperature overnight. The same workup as described for 12 
afforded 800 mg (87%) of 13 as a brown oil: 1H NMR δ 11.21 (br s, 1H), 9.35 (br s, 1H), 8.90 
(br s, 1H), 6.86 (br s, 1H), 6.13 (s, 1H), 5.69 (m, J = 2, 1H), 4.35 (s, 8H), 3.88 (q, J = 7, 2H), 
3.84 (d, J = 9.5, 2H), 3.77 (s, 2H), 3.45 (q, J = 7.5, 2H), 2.66 (s, 3H), 1.98-1.92 (m, 4H), 1.78-
1.53 (m, 6H), 1.53-1.41 (m, 4H), 1.24-1.09 (m, 2H), 0.98 (m, J = 9, 3H); 13C NMR (125 MHz, 
CDCl3) δ 171.9, 169.6, 167.6, 167.0, 159.0, 154.0, 148.5, 146.2, 135.9, 127.0, 126.1, 103.2, 
102.2, 66.3, 64.6, 62.2, 60.8, 49.0, 40.0, 32.7, 32.0, 31.0, 30.2, 30.1, 28.7, 28.7, 27.0, 26.1, 25.6, 
19.2, 18.1, 13.7. ESI-HRMS calcd for (C32H45N5O10·H)+ 660.3245, found 660.3234. 
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Polymer 14. A solution of 800 mg (1.2 mmol) of 13 and 1.98 g (13.9 mmol) of BMA, passed 
through a column of dry basic aluminum oxide, in 120 mL of DMSO was stirred at room 
temperature. A stream of Ar was bubbled through for 30 min. In one portion was added 99.2 mg 
(0.6 mmol) of AIBN and Ar was bubbled for 10 min. The mixture was sealed with a rubber 
septum and heated to 60 °C for 12 h. The polymerization was quenched by rapid freezing in 
liquid nitrogen. The crude was diluted with 100 mL of CHCl3 and washed with 120 mL of water. 
The water layer was extracted twice with 80 mL of DCM. The organic layers were combined, 
washed with 150 mL saturated brine, dried over sodium sulfate, gravity filtered and concentrated 
using a rotary evaporator. The crude was dissolved in 8 mL of CHCl3 and dispersed into 800 mL 
of methanol. The unreacted monomer 13 was soluble in methanol. The polymer was collected by 
centrifuge. This process was repeated twice. The collected polymer was dried in vacuo at 40 °C. 
1H NMR (DMSO-d6 : CDCl3 = 1 : 19) δ 10.90 (s, NH), 8.89 (s, NH), 6.38 (s, CH), 4.23 (s, 
OCH2CH2O in BMA-DeUG), 3.95-3.78 (br m, CH2 in BMA), 3.72 (d, CH2), 3.63 (s, CH2), 3.22 
(s, CH2), 2.00-0.88 (br m, CH2 and CH3). 
2.6.3 Multicycle Redox Experiments 
 To a 4 mL vial was added 0.4 mg (1.3 µmol) of a catalytic amount (10 mol%) of salcomine 
in a CDCl3 solution and the solution was treated with stream of O2 for 15 min. One equivalent 
(eq.) 1red and 2 were added and the mixture was treated with O2 for 2 h. The color of the solution 
changed from bright orange to dark red. A 1H NMR spectrum (ox-1st) was collected and a 
stream of N2 was bubbled through the solution for 5 min. To the solution was added 2 eq. 
hydroquinone and the mixture was stirred at room temperature for 30 min. A second 1H NMR 
spectrum (red-1st) was collected and the excess hydroquinone was filtered away. To the solution 
was added 0.1 eq. salcomine and the mixture was treated with O2 for 2 h. 1H NMR spectrum (ox-
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2nd) was collected and a stream of N2 was bubbled through the solution for 5 min. To the 
solution was added another 2 eq. hydroquinone and mixture was stirred at room temperature for 
30 min. 1H NMR spectrum (red-2nd) was collected and the excess hydroquinone was filtered 
away. This procedure was repeated twice to get 1H NMR spectra ox-3rd, red-3rd, ox-4th and red-
4th. 
2.6.4 ITC Experiments  
A typical ITC procedure is described below. Concentrations and experimental parameters 
varied from experiment to experiment. The reference cell was scrupulously rinsed and dried 
before being filled with solvent (dry chloroform). HPLC grade chloroform (CHCl3) was passed 
through a column of dry basic aluminum oxide. The sample cell was filled with a dilute solution 
of host after rinsing and drying and the syringe was filled with a solution of guest. The titration 
was carried out using the following parameters: total number of injections, 40 to 50; injection 
volume, 5 µL; injection duration, 10 s; injection spacing, 180 s; cell temperature, 25 °C; and 
stirring speed, 310 rpm. The heat of dilution of the guest in CHCl3 was determined and 
subtracted from the data after using ORIGIN 5.0 software (Microcal, Inc.) to generate a binding 
curve via the single-site binding model. The fit of the binding curve reveals the association 
constant (Ka), enthalpy change (ΔH), entropy change (ΔS) and binding stoichiometry (n). 
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Chapter 3 
Crosslinked Dendronized Polyols (CDPs) as a General Approach  
to Brighter and More Stable Fluorophores 
 
Part of this chapter is adapted from the following publication: 
Ying Li, Yugang Bai, Nan Zheng, Yang Liu, Gretchen A. Vincil, Benjamin J. Pedretti, Jianjun 
Cheng, and Steven C. Zimmerman,* Crosslinked Dendronized polyglyols as a General Approach 
for Brighter and More Stable Fluorophores, Chem. Commun., 2016, 52, 3781–3784. 
  
Collaboration and contribution statement:  
Syntheses of fluorescent monomers were performed in collaboration with Yugang Bai and 
Gretchen A. Vincil. Benjamin J. Pedretti, an undergraduate, helped synthesize some of the 
dendronized monomer. The cellular uptake, confocal microscopy and cytotoxicity study were 
performed in collaboration with Nan Zheng and Yang Liu.  
  
  
3.1 Introduction 
Fluorescent probes have been widely used in bioimaging, especially for monitoring 
supramolecular and biological processes at the molecular level.1-4 To best enable these 
applications, aqueous-soluble, bright, photo-stable, and biocompatible fluorophores are needed. 
To achieve aqueous solubility, dyes can be linked to charged functional groups5 or aqueous 
soluble macromolecules.6-9 Efforts toward achieving other desirable properties include the design 
of new more stable fluorophores,10-11 the introduction of antifading agents,12-13 the conjugation to 
functional species,14 the attaching of protective sheaths15 and scaffolds.16 However, it is still not 
trivial to realize all these desirable features simultaneously.  
     Polyglycerol dendrimers (PGD) are globular macromolecules with multiple hydroxyl groups 
at their periphery.17-21 PGD have attracted considerable interest because of their high 
biocompatibility and charge-free character across a wide pH range.22 They have been reported to 
enhance the aqueous solubility and brightness of dyes6-7 and to reduce the blinking of 
hydrophobic fluorescent dyes.9 However, the incorporation of fluorophores onto the polyglycerol 
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scaffold is nontrivial and generally limited to either a single copy at the core, or multiple copies 
at the periphery.  
     A less explored macromolecular architecture for solubilizing and stabilizing fluorophores is 
the linear dendronized polymer. These polymers can be prepared by grafting dendrons onto the 
repeating units of a linear polymeric backbone, or can be prepared directly through the 
polymerization of dendronized monomers.23-25 As the dendron generation increases, direct 
polymerization can be increasingly demanding because of the growing steric crowding. In this 
regard, ring-opening metathesis polymerization (ROMP) has been successfully applied to the 
synthesis of this challenging macromolecular structure because of its rapid polymerization rate 
and the high functional-group-tolerance of the catalyst.26-28 Dendronized polymers can be further 
diversified by copolymerizing different monomers while maintaining the high density of 
functional groups along the backbone.29-30 To our knowledge, little research has been directed 
toward crosslinking high-generation (g ≥ 3) dendronized polymers.31 Herein, we report the 
synthesis and study of crosslinked dendronized polyols (CDPs) as a general platform for 
fluorescent dye encapsulation and protection using a sequential ROMP and intra-chain ring-
closing metathesis (RCM) process. 
3.2 Synthesis of Monomers 
The preparation of 3rd-generation dendron monomers can readily be achieved on a ten-gram 
scale despite the multistep synthesis. Considering the small amount of material needed for most 
fluorescence studies, the scale of ten grams is considerably large. The monomer synthesis started 
from the protected dendron module in a divergent fashion. Once the dendron reached the desired 
generation, the core of the dendron was converted to a primary amine, which can be easily 
coupled to an exo-norbornenyl moiety by amide formation (Scheme 3.1). The TBDPS-protected 
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polyglycerol dendron (Compound 1) was synthesized from the corresponding TBDPS-protected 
allyl alcohol according to previously published procedures.32 
Scheme 3.1 Schematic illustration of the synthesis of the PGD monomer  
 
To demonstrate the generality of the new CDP approach for dye encapsulation and protection, 
we selected five representative and commonly used dyes, which are readily available and have 
emission wavelengths ranging from 450 nm to 590 nm, thereby covering most of the visible 
spectrum. The five dyes are 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY or B), 
coumarin (C), fluorescein (F), perylene diimide (PDI or P) and rhodamine (TAMRA or R). Each 
could be conveniently linked to an exo-norbornenyl moiety (Scheme 3.2). Indeed, these ROMP 
monomers were prepared on gram-scale in just two or three steps as detailed in Section 3.6. The 
phenol groups of F were protected by esterification with acetic anhydride using a reported 
procedure.33 All the other fluorophores C, B, P, and R are inherently compatible with the 
operation of the alkene metathesis catalysts, i.e., Grubbs’ 1st and 3rd catalysts34-35 because no 
isolated alkenes are present and all the amino groups are alkylated.  
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Scheme 3.2 Synthesis of fluorophore monomers MC, MB, MP and MR 
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3.3 Synthesis of CDPs 
For the preparation of CDPs, M1 (an active ester) and M2 (a protected polyglycerol dendron) 
were used in all of the polymerizations along with one of five different Mx’s, where X = C, B, F, 
P, and R as described above. With the appropriate monomers (M1, M2, Mx) in hand, the 
synthesis of fluorescent CDPs required four steps as outlined in Scheme 3.3. First, a linear, 
random block copolymer was synthesized by ROMP using a 25:50:2 feed ratio of M1, M2, and 
Mx. Postfunctionalization with triallyl-O-tris, intra-chain RCM, and hydrolysis afforded aqueous 
soluble, fluorescent, dendronized polymers with a semi-rigid and compact macromolecular 
structure. A similar ROMP-RCM strategy was used recently to prepare polymeric organic 
nanoparticles (ONPs) that protected fluorescein.33 However, a dihydroxylation step with 
potassium osmate36 was required to provide aqueous solubility preventing generalization of the 
method to more reactive dyes such as BODIPY and coumarin.  
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Scheme 3.3 The synthetic scheme of the crosslinked dendronized polymer pX 
 
1) 3rd-generation Grubbs catalyst, DCM; 2) triallyl-O-tris, nitrobenzene, DCM, 40 °C; 3) 1st-
generation Grubbs catalyst, DCM, high dilution condition; 4) TFA, DCM, acetone, H2O, 40 °C. 
X represents the specific dye incorporated. The corresponding emission wavelengths of different 
dyes are displayed on the visible spectrum. 
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The successful synthesis of the dye-conjugated, dendronized polymers was confirmed by 1H 
NMR, dynamic light scattering (DLS), gel permeation chromatography (GPC) coupled with a 
multi-angle laser light scattering (MALLS) detector. Comparing 1H NMR spectra of pF-1 to pF-
2 (Figure 3.1), the new proton signals centered at ca. δ 5.24 and 5.16 ppm and corresponding to 
olefin groups indicated the successful incorporation of the triallyl-O-tris. Intra-chain crosslinking 
via RCM under the high-dilution condition was verified by the almost complete disappearance of 
the terminal alkene proton signals and the narrow polymer GPC traces with slightly longer 
retention time (Figure 3.2). MALLS analysis of pF-1 and pF-2 showed a molecular weight of 84 
kDa (PDI = 1.08) and 79 kDa (PDI = 1.12), respectively. The molecular weight of the other 
fluorescent dendronized polymers could not be determined in the same way because the 
fluorescence emission of their fluorophores interfered with the MALLS detector. However, their 
GPC retention times were comparable to pF-1 and pF-2, suggesting similar molecular weights 
(Figure 3.3).  
	  
Figure 3.1 Overlay of truncated 1H-NMR spectra of polymers after linear polymerization (pF-
NHS), triallyl-O-tris incorporation (pF-1) and RCM (pF-2). The protons signals absent after 
RCM are highlighted. 
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The previously prepared ONPs showed a much larger increase in retention time upon RCM 
(e.g., > 1 min).33 Both polymeric nanostructures are essentially fully cross-linked according to 
NMR, so the different extent of contraction observed with the ONPs and CDPs (Figure 3.2), can 
be attributed to a more compact structure already present in the pre-cross-linked dendronized 
polymer. Indeed, because of the densely packed dendrons along the polymer backbone, the linear 
dendronized polymer tends to adopt semi-rod-like structure.27-28, 37-40 As a result, the CDPs might 
contain primarily short-range cross-links, whereas the more flexible ONPs might favor the long-
range RCM commonly observed in dendrimers.41-43 
 
Figure 3.2 GPC traces of pF-1 and pF-2. 
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Figure 3.3 GPC traces of (a) pX-1 and (b) pX-2. (X = B, C, F, P, R) 
With the completion of the RCM, attention was turned to the deprotection of the dendrons. 
Different acids, including aqueous TFA, HCl, H2SO4, and Dowex resin were screened and dilute 
aqueous TFA solution was found to remove the acetal groups efficiently while maintaining the 
fluorophore integrity. DLS analysis of pF indicated a hydrodynamic size of ca. 6 nm and the 
other CDPs were assumed to have similar sizes (Figure 3.4). This size is close to that of a 
	  
	  
51	  
recently developed quantum dot and in the appropriate size range for biomolecule labeling 
applications.44-45  
 
Figure 3.4 DLS analysis of pF. 
3.4 Quantum Yield Measurements and Photobleaching Studies 
The quantum yield (QY) of the pXs and free dyes were determined using fluorescein as the 
standard (QY = 0.95).46-47 The brightness for each CDP was calculated as one-thousandth of the 
product of QY and molar extinction coefficient (Table 1). The fluorescein and TAMRA units 
exhibited similar QYs in the CDPs (i.e., pF and pR) and free solution whereas pB and pP were 
dramatically brighter than free BODIPY and PDI, respectively. The quantum yield of coumarin 
decreased by more than half once incorporated in the CDP, which might stem from the 
sensitivity of coumarin’s spectral properties towards the micro-environment.48-49 An 
enhancement in brightness was observed for all five chromophores, including coumarin, because 
each CDP contains two fluorophores on average. However, the results for pB and pP far 
exceeded a factor of two, suggesting that the polymer scaffolds not only provided aqueous 
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solubility but also inhibited dye–dye quenching.50-51 For pP, additional evidence for the scaffold 
inhibiting PDI π–π stacking comes from its UV-visible spectrum (Figure 3.5).  
Table 3.1 QY and brightness of free dyes and polymers  
Fluorophore	  
Free	  Fluorophores	   pX	  
QY	  (%)	   Brightnessb	  (M-­‐1cm-­‐1)	   QY	  (%)	   Brightnessb	  (M-­‐1cm-­‐1)	  
coumarin	   96	   9.9	   34	   13	  
BODIPYa	   1.3	   0.056	   46	   22	  
fluorescein	   9514	   71	   71	   112	  
PDIa	   3.3	   0.97	   4.6	   3.6	  
rhodamine	   12	   11	   11	   20	  
a	  Water-­‐insoluble	  fluorophores	  (BODIPY	  and	  PDI)	  were	  first	  dissolved	  in	  dioxane	  and	  
then	  diluted	  with	  0.1	  M	  aqueous	  phosphate	  buffer	  (pH	  =	  7.4).	  	  
b	  Brightness	  =	  QY・ ︎molar	  extinction	  coefficient/1000.	  	  
 
Figure 3.5 UV-Vis spectrum (350-650 nm) of pP. 
The relative photostability of the pXs and their respective free dyes were compared by 
irradiating the pX or fluorophore (ca. 100 nM) in phosphate buffer (PB, pH 7.4) with an LED 
light source (470 nm). Water-insoluble BODIPY and PDI were dissolved in dioxane first, and 
then diluted with PB so that their photobleaching behavior could be studied in aqueous solution. 
The polymer and free-dye samples in cuvettes were placed in a black box and the distance 
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between the samples and the LED was 10 cm. The cuvettes were capped to prevent solvent 
evaporation and concentration change. Every 30 min, the samples were taken out of the box and 
directly measured in a fluorospectrometer. The fluorescence intensity was measured, recorded, 
and plotted against irradiation time	  (Figure 3.6).  
Significantly improved photostability was observed in the case of pC, pF and pP. After 4 h 
of irradiation, pC and pP maintained about 55% of their initial fluorescence intensity whereas 
the free coumarin and PDI’s intensity quickly dropped to the background level. Similarly, the 
final fluorescent intensity of pF was about 14 times higher than that of free fluorescein. TAMRA 
is known as a very robust fluorophore, and its stability was well preserved when incorporated to 
the CDPs. It was difficult to compare the photostability of pB and free BODIPY because the 
resulting BODIPY solutions had very low quantum yields (< 1%). PEG-conjugated BODIPY 
and PDI were also prepared and studied. In the case of BODIPY, the photostability was 
significantly reduced upon PEG conjugation whereas PEG-functionalized PDI exhibited an even 
lower QY. These PEG conjugation studies indicated that linear PEG cannot protect BODIPY nor 
prevent PDI from dye-dye quenching. To better illustrate the stabilization effect of CDPs, the 
relative fluorescence intensity was plotted overtime for all five fluorescent CDPs and their 
corresponding free dye solutions (Figure 3.7). 
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Figure 3.6 Absolute Fluorescence intensity over time during the photobleaching study: (a) C and 
pC; (b) B and pB; (c) F and pF; (d) PDI and pP; (e) R and pR; (f) pictures of CDP solutions 
(0.5 mg/mL, illuminated with TLC UV lamp, 365 nm). 
     Polyvinyl alcohols such as Mowiol 4-88 are known to act as anti-fading agents for fluorescent 
microscopy.52 This type of polymer also carries multiple hydroxyl groups analogous to the CDPs, 
although the mechanism of the stabilization is not known. To test whether the free fluorescent 
dyes can be stabilized with CDPs as additives, control studies were performed by preparing a 
CDP without Mx and mixing it with free dyes (1:2 molar ratio) at the same concentration as used 
for pXs. No photostabilization was observed, indicating the importance of the covalent 
encapsulation of the dyes in the CDPs. 
	  
	  
55	  
	  
Figure 3.7 Normalized fluorescence intensity over time during photobleaching study of pX 
compared with free dyes: (a) pC and coumarin; (b) pB and BODIPY-PEG2k; (c) pF and 
fluorescein; (d) pP and PDI-PEG2k; (e) pR and rhodamine. The corresponding excitation and 
maximum emission wavelengths are indicated. 
3.5 Cell Uptake and Cytotoxicity Studies 
To explore the potential of these fluorescent CDPs in applications such as bioimaging and 
cellular delivery, cytotoxicity and cell uptake studies were performed. The toxicity of all the 
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CDPs was measured in HeLa cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) cell viability assay. All five polymers exerted minimal cytotoxicity 
at a concentration as high as 100 µg/mL (Figure 3.8). HeLa cells were seeded on 96-well plates 
at 1×104 cells/well and cultured in serum-containing media for 24 h. The medium was replaced 
with fresh DMEM containing serum (100 µL/well), into which polymers were added at the final 
concentrations of 100, 50, 20, and 10 µg/mL, respectively. After incubation at 37 °C for 4 h, the 
medium was changed to fresh serum-containing DMEM and cells were further cultured for 24 h 
before viability assessment by the MTT assay. Results were represented as percentage viability 
of control cells that did not receive polymer treatment. 
	  
Figure 3.8 MTT toxicity study of pX (X = C, B, F, P and R). The Y-axis shows % cell viability. 
The distribution CDPs after cell uptake was studied by confocal laser scanning microscopy. 
HeLa cells cultured on coverslips in 6-well plate were incubated with polymer in DMEM (2 mL) 
at 15 µg polymer/well. Following incubation for 4h, cells were washed three times with PBS, 
fixed with 4% paraformaldehyde, and stained with Hoechst 33258 (2 µg/mL) before observation 
by confocal laser scanning microscopy (CLSM, LSM700, Zeiss, Germany). Similar to 
nondendronized ONPs, confocal microscopy showed that all five CDPs readily entered the cells 
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(Figure 3.9). Interestingly, although the ONPs were largely localized in endosomes,33 the 
fluorescence of the CDPs was observed throughout the cytoplasm (Figure 3.10). An in-depth 
study of the internalization and intracellular trafficking mechanism is beyond the scope of the 
current study, but this is an intriguing result.  
 
Figure 3.9 Confocal microscopy images of HeLa cells treated with pX. First row: blue channel 
images showing nucleus staining with Hoechst; second row: fluorescence images from pX; third 
row: overlay of nucleus and fluorescence from pX. (X = C, B, F, P and R). 
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Figure 3.10 Confocal microscopy images of HeLa cells treated with polymers. Left: non-
dendronized organic nanoparticles [5 µM, 6 h incubation, fixed cells]33; right: crosslinked 
dendronized polyols (CDPs) [95 nM, 4 h incubation, fixed cells].  
3.6 Conclusions 
In conclusion, we have developed a new approach to construct brighter and more stable 
polymeric fluorophores. The incorporation of dendronized polyglycerol monomers affords high 
aqueous solubility as well as enhanced photo-stability.  By avoiding the use of potassium osmate, 
the current approach has allowed a much broader range of fluorophores to be used. Multiple 
copies of dyes can be introduced onto the crosslinked dendronized polyglycerols, which 
increases the brightness. The availability of these polymeric nanoparticles to cytoplasm opens 
the door to more applications in the future. The different cellular localization patterns of ONPs 
and CDPs may be used to tailor cellular delivery vehicles for different purposes. 
3.7 Experimental 
3.7.1 General Methods 
The general instrument setup was described in Section 2.6. A ThorLabs 470 nm LED 
(M470L3) regulated with T-cube LED Driver (LEDD1B) set to 1000 mA (reported to produce 
710 mW) was used for the photobleaching studies.  
  
	  
	  
59	  
3.7.2 Synthesis of Monomers 
 
Compound 2. To a solution of 1 (1.24 g, 1.6 mmol) and 2,2’-dimethoxypropane (8 ml, 65 mmol) 
in 10 mL of DMF was added 4-toluenesulfonic acid (1.04 g, 6.0 mmol). The mixture was stirred 
overnight at 60 °C. The reaction was quenched by adding TEA (0.5 ml, 3.6 mmol) and 
concentrated using a rotary evaporator. The mixture was redissolved in DCM and washed with 
water and brine. The organic layer was dried over Na2SO4 and the solvent was removed under 
vacuum. The crude product was purified by gradient column chromatography (EtOAc : Hex = 1 : 
4 to 1 : 1) to give 1.2 g (82%) of the product as a brown oil. 1H NMR δ 7.65 (br, 4H), 7.41 (br, 
2H), 7.38 (br, 4H), 4.21 (br, 4H), 4.01 (br, 4H), 3.75-3.40 (br, 28 H), 1.39 (m, 12H), 1.10 (m, 
12H), 1.04 (s, 9H).  
Compound 3. To a solution of 2 (2 g, 2.1 mmol) in 15 mL of THF was added TBAF (1 M in 
THF, 4 mL, 4 mmol). The mixture was stirred at room temperature overnight and concentrated 
down under vacuum. The mixture was redissolved in DCM and washed with water and brine. 
The organic layer was dried over Na2SO4 and the solvent was removed using a rotary evaporator. 
The crude product was purified by gradient column chromatography (EtOAc : Hex = 1 : 4 to 1 : 
0) to give 1.3 g (87%) of the product as a yellow oil. 1H NMR δ 4.27 (br, 4H), 4.05 (br, 4H), 4.00 
(m, 2H), 3.72 (m, 4H), 3.63-3.48 (br, 20 H), 2.65 (br, 2H), 1.42 (br, 12H), 1.36 (br, 12H). ESI-
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LRMS (m/z): calcd for [M+H]+ 697.4; found, 697.6. 
Compound 4. To a solution of 3 (1.31 g, 1.9 mmol) and 4-toluenesulfonic chloride (1.43 g, 7.5 
mmol) in 10 mL of DCM was added TEA (3.2 mL, 23 mmol). The mixture was washed with sat. 
NH4Cl aqueous solution and brine. The organic layer was dried over Na2SO4 and the solvent was 
removed using a rotary evaporator. The crude product was purified by gradient column 
chromatography (EtOAc : Hex = 1 : 4 to 2 : 1) to give 1.28 g (80%) of the product as a yellow oil. 
1H NMR δ 7.79 (d, J=8.5 Hz, 2H), 7.35 (d, J=8.5 Hz, 2H), 4.25 (m, 4H), 4.04 (m, 4H), 3.75-3.40 
(br, 27 H), 2.46 (s, 3H), 1.41 (br, 12H), 1.34 (br, 12H). ESI-LRMS (m/z): calcd for [M+H]+, 
851.4; found, 851.5. 
Compound 5. To a solution of 4 (3.4 g, 4.0 mmol) in 10 mL of DMF was added sodium azide (4 
g, 62 mmol). The mixture was heated overnight at 90 °C and concentrated using a rotary 
evaporator. The crude product was purified by gradient column chromatography (EtOAc : Hex = 
1 : 4 to 1 : 2) to give 2.8 g (97%) of the product as a light yellow oil. 1H NMR δ 4.25 (br, 4H), 
4.04 (m, 4H), 3.78-3.43 (br, 25 H), 3.38 (br, 1H), 3.30 (br, 1H), 1.41 (br, 12H), 1.35 (br, 12H). 
ESI-LRMS (m/z): calcd for [M]+ 721.4; found, 744.3 [M+Na]+. 
Compound 6. To a solution of 5 (0.5 g, 0.69 mmol) in 10 mL of MeOH was bubbled through N2 
for 30 min and added 10% palladium on carbon (30 mg, 0.028 mmol). The mixture was charged 
with H2 up to 200 psi and stirred overnight at room temperature. The reaction bomb was vented 
and the mixture was filtered with a celite plug. The filtration was concentrated down under 
vacuum and used without further purification. 1H NMR δ 4.25 (br, 4H), 4.04 (m, 4H), 3.78-3.38 
(br, 25 H), 2.85 (br, 1H), 2.73 (br, 1H), 1.50 (br, 2H), 1.40 (br, 12H), 1.35 (br, 12H). ESI-LRMS 
(m/z): calcd for [M+H]+ 696.4; found, 696.4. 
Compound M2. To a solution of 6 (695.8 mg, 1 mmol) and N-Glycine cis-5-norbornene-endo-
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2,3-dicarboximide (230 mg, 1.04 mmol) in 10 mL of DCM was added DMAP (12 mg, 0.1 mmol) 
and EDC (0.4 mg, 2 mmol). The mixture was stirred overnight at room temperature and washed 
with brine. The organic layer was dried over Na2SO4 and the solvent was removed using a rotary 
evaporator. The crude product was purified by gradient column chromatography (EtOAc : Hex = 
1 : 4 to 2 : 1) to give 819 mg (91%) of the product as an orange oil. 1H NMR δ 6.29 (s, 2H), 4.24 
(br, 4H), 4.13 (br, 2H), 4.04 (m, 4H), 3.78-3.42 (br, 28 H), 3.30 (s, 2H), 2.71 (s, 2H), 1.88 (d, 
J=10 Hz, 1H), 1.51 (d, J=10 Hz, 1H), 1.41 (br, 12H), 1.35 (br, 12H). ESI-LRMS (m/z): calcd for 
[M+H]+ 899.5; found, 899.4, 921.4 [M+Na]+. High-performance liquid chromatography 
(HPLC) coupled to diode array UV detection and mass spectrometry was performed to confirm 
the purity of M2. The elution time data and mass spectrum data were shown in Figures 3.11 and 
3.12. 
  
Figure 3.11 HPLC spectrum for M2 (dissolved in DMSO and MeOH). Note: purity of target 
compound at 6.6 min is about 98.2 %. 
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Figure 3.12 Mass spectrum for M2 (the above peak at 6.6 min) 
 
Compound 753 and 933 were synthesized according to previous reported procedure. 
Compound 8. To a suspension of 7 (2 g, 6.7 mmol) in 30 mL of MeOH was added 10 mL of 4 
M LiOH aqueous solution. The mixture was stirred at room temperature for 2 h and became clear 
solution. The solution was acidified with 4M HCl and extracted with DCM for multiple times. 
The organic layers were combined, dried over Na2SO4 and concentrated down in vacuo to afford 
580 mg (30%) of the product as a brown solid. The crude was used in the next step without 
further purification. 1H NMR is consistent with literature.53  
Compound MC. A solution of 16 (200mg, 0.70 mmol) and 14 (183.9 mg, 0.83 mmol) in 4 mL of 
DCM was added DMAP (40 mg, 0.16 mmol) and EDC (400 mg, 2.1 mmol). The mixture was 
stirred overnight at room temperature, washed with saturated brine, dried over Na2SO4, the 
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solvent removed using a rotary evaporator. The crude product was purified by gradient column 
chromatography (EtOAc : Hex = 1 : 4 to 1 : 1) to give 315 mg (92%) of the product as a dark 
yellow solid. 1H NMR δ 9.03 (br, 1H), 8.56 (s, 1H), 6.98 (s, 1H), 6.27 (s, 2H), 3.58 (m, 2 H), 
3.41 (m, 2H), 3.31 (m, 4H), 3.27 (s, 2H), 2.87 (m, 2H), 2.76 (m, 2H), 2.69 (s, 2H), 1.96 (br, 4H), 
1.87 (m, 2H), 1.51 (d, J=10 Hz, 1H). 13C NMR δ 178.14, 163.76, 162.99, 152.70, 148.04, 137.89, 
127.04, 119.63, 109.00, 108.26, 105.70, 53.55, 50.29, 49.87, 47.90, 45.24, 42.89, 37.04, 36.42, 
28.19, 27.52, 21.21, 20.27, 20.15. ESI-HRMS (m/z): calcd for [M+H]+ 488.2185; found, 
488.2178. 
 
Compound 10 was prepared according to previous reported procedure.54 
Compound 11. The mixture of cis-5-norbornene-exo-2,3-dicarboximide (1.5 g, 9.2 mmol), p-(2-
bromoethoxy)benzaldehyde (2.1 g, 9.2 mmol) and K2CO3 (3.0 g, 21.7 mmol) in 25 mL of 
ethanol was refluxed for 15 hours. The solvent was removed by rotavap and the residue was 
purified by column chromatography (EtOAc : Hex = 1 : 5) to give 2.1 g (73%) of the product as 
a yellow oil (73%). 1H NMR (400 MHz): δ 9.85 (s, 1H), 7.80 (d, 2H), 6.93 (d, 2H), 6.25 (s, 2H), 
4.22 (t, 2H), 3.93 (t, 2H), 3.25 (s, 2H), 2.68 (s, 2H), 1.44 (d, 1H), 1.23 (d, 1H). 
Compound MB. Synthesis of the BODIPY was analogous to a previously published protocol.55 
The synthesized N-(2-(p-formylbenzoxy)ethyl) cis-5-norbornene-exo-2,3-dicarboximide (1.26 g, 
4.0 mmol) was mixed with cryptopyrrole (1.0 g, 8.1 mmol) in 20 mL of DCM. A few drops of 
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trifluoroacetic acid were added. The dark reaction mixture was stirred at room temperature until 
total disappearance of the aldehyde. Chloranil (0.98 g, 4.0 mmol) was added and the solution 
stirred for 5 min. DIPEA (3.62 g, 28 mmol) and trifluoroborate etherate (6.24 g, 44 mmol) were 
added successively. The mixture was stirred at room temperature overnight. The filtrate was 
concentrated and the residue was purified by chromatography on silica (DCM : Hex = 5 : 1). The 
obtained orange-red solid was then suspended in 25 mL of 1:1 ether : Hex mixture, sonicated, 
and filtered to give the pure product (1.4 g, 60%). 1H NMR δ 7.15 (d, J = 8.6 Hz, 2H), 6.95 (d, J 
= 8.6 Hz, 2H), 6.32 (t, J = 1.7 Hz, 2H), 4.22 (t, J = 5.8 Hz, 2H), 3.97 (t, J = 5.8 Hz, 2H), 3.32 (t, 
J = 1.5 Hz, 2H), 2.75 (d, J = 1.0 Hz, 2H), 2.53 (s, 6H), 2.30 (q, J = 7.5 Hz, 4H), 1.48 (dt, J1 = 9.8 
Hz, J2 = 1.5 Hz, 1H), 1.34 (d, J = 9.8 Hz, 1H), 1.31 (s, 6H), 0.99 (t, J = 7.5 Hz, 6H). 13C NMR δ 
178.09, 158.60, 153.71, 140.11, 137.97, 132.81, 131.25, 129.65, 128.61, 115.15, 63.90, 48.03, 
45.48, 42.72, 37.85, 17.21, 14.78, 12.63, 11.96. 11B NMR (128 MHz, CDCl3): δ 0.85 (t, J = 33.4 
Hz). 19F NMR (376 MHz, CDCl3): δ -146.3 (q, J = 33.5 Hz). ESI-HRMS (m/z): calcd for 
[M+H]+ 586.3053; found, 586.3047. 
 
Compound MP. 1,6,7,12-Tetrachloroperylene tetracarboxylic acid dianhydride (532 mg, 1.00 
mmol), N-(3-aminopropyl) cis-5-norbornene-exo-2,3-dicarboximide (231 mg, 1.05 mmol) and 
tert-butyl aminoacetate hydrochloride (176 mg, 1.05 mmol) were mixed in 15 mL of dry 
pyridine. The mixture was heated to 80 oC to generate a homogeneous solution, and was kept 
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stirring for 20 h. Solvent was removed using a rotary evaporator, and the residue was purified by 
gradient column chromatography (EtOAc : Hex = 1:5 to 1:3) to give the monomer as a bright 
orange powder (210 mg, 25%). 1H NMR δ 8.71 (s, 2H), 8.68 (s, 2H), 6.32 (t, J = 1.5 Hz, 2H), 
4.89 (s, 2H), 4.25 (t, J = 7.4 Hz, 2H), 3.66 (t, J = 6.9 Hz, 2H), 3.32 (t, J = 1.9 Hz, 2H), 2.74 (d, J 
= 1.0 Hz, 2H), 2.07 (tt, J1 = 7.4 Hz, J2 = 6.9 Hz, 2H), 1.59 (d, J1 = 9.4 Hz, 1H), 1.53 (s, 9H), 1.34 
(d, J = 9.4 Hz, 1H). 13C NMR δ 178.22, 178.07, 166.65, 162.30, 162.09, 138.01, 137.96, 135.63, 
135.53, 133.35, 133.15, 131.58, 131.55, 129.02, 128.81, 123.55, 123.40, 123.19, 122.91, 82.94, 
48.05, 48.04, 47.99, 45.36, 45.30, 42.98, 42.95, 42.45, 38.69, 36.59, 36.35, 28.20, 26.85, 26.48. 
MALDI-TOF (m/z): calcd for [M+H]+ 846.1; found 846.1, 791.1 [M minus tert-butyl] +. 
 
Compound 17. To a suspension of dimethylaminophenol (9.999 g, 73.0 mmol) and 1,2,4-
benzenetricarboxy-anhydride (7.008g, 36.5 mmol) in 500 mL of propionic acid was added p-
toluene sulfonic acid (322 mg, 1.6 mmol). The mixture was refluxed for two days. The solvent 
was removed via rotary evaporation and azeotroped with water. The crude product was purified 
by gradient column chromatography (MeOH:DCM = 1:4 to 3:2) to give 1.88 g (11.9%) a dark 
purple solid (a mixture as 5/6 isomer in an approx. 4:5 ratio, 1.88 g, 4.35 mmol, 11.9 %). 1H 
NMR (500 MHz; CD3OD): δ 8.79 (d, 1.5 1H), 8.27 (d, 1.2 1H), 8.25 (d, 1.6 1H), 8.17 (d, 8.2 1H), 
7.86 (d, 1.6 1H), 7.38 (d, 7.9 1H), 7.25 (d, 9.5 2H), 7.23 (d, 9.5 2H), 7.032 (dd, 9.5, 1.0 2H), 
7.027 (dd, 9.4, 0.8 2H), 6.93 (d, 2.6 2H), 6.92 (d, 2.6 2H), 3.28 (s, 24H). ESI-LRMS (m/z): calcd 
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for [M+H]+ 431.1; found 431.0. 
Compound MR. To a solution of 5(6)-carboxytetramethylrhodamine (578 mg, 1.38 mmol) and 
NHS (168 mg, 1.46 mmol, 1.05 eq.) in 15 mL of dry DMF was added EDC-HCl (315 mg, 1.85 
mmol, 1.3 eq.). The mixture was allowed to stir at room temperature for 20 min. To the mixture 
was added exoC4NH2 (350 mg, 1.49 mmol, 1.08 eq.) and the reaction was stirred overnight at 
room temperature. The DMF was removed via rotary evaporation and the residue was dissolved 
in EtOAc. The organic layer was washed with water, 0.1 M HCl, and brine. The organic layer 
was dried over MgSO4 and concentrated using a rotary evaporator. The crude product was 
purified via gradient column chromatography (MeOH : DCM = 1 : 9 to 1 : 3) to give a dark 
purple solid (a mixture of 5/6 isomers, 700 mg, 79 %). Note: isomers could be separated with 
careful chromatography. Isomer 5: 1H NMR (CD3OD): δ 8.66 (d, 1.5 1H), 8.16 (dd, 7.9, 1.5 1H), 
7.45 (d, 7.9 1H), 7.18 (d, 9.5 2H), 7.04 (dd, 9.5, 2.4 2H), 6.96 (d, 2.4 2H), 6.33 (t, 1.7 2H), 3.55 
(m, 2H), 3.48 (m, 2H), 3.30 (s, 12H), 3.19 (t, 1.7 2H), 2.73 (d, 1.1 2H), 1.68 (m, 4H), 1.50 (dt, 
9.8, 1.4 1H), 1.26 (d, 9.8 1H). isomer 6: 1H NMR (CD3OD): δ 8.27 (d, 8.2 1H), 8.12 (dd, 8.2, 1.8 
1H), 7.74 (d, 1.8 1H), 7.20 (d, 9.5 2H), 7.04 (dd, 9.5, 2.5 2H), 6.96 (d, 2.5 2H), 6.30 (t, 1.7 2H), 
3.48 (m, 2H), 3.40 (m, 2H), 3.30 (s, 12H), 3.12 (t, 1.6 2H), 2.68 (d, 1.0 2H), 1.60 (m, 4H), 1.42 
(dt, 9.8, 1.4 1H), 1.18 (d, 9.8 1H). ESI-LRMS (m/z): calcd for [M+H]+ 647.3; found: 647.1. 
3.7.3 Synthesis of Polymers 
Typical procedure for pX-1 (X= C, B, F, P and R). 
Mx (12 nmol, 2 eq), M1 (0.15 mmol, 25 eq) and M2 (0.3 mmol, 50 eq) were dissolved in 
anhydrous DCM (5 mL). Pyridine-modified Grubbs 2nd Generation catalyst (0.03 M in DCM, 
0.02 mL, 6 nmol, 1 eq) was added. The solution was stirred at room temperature for 30 min 
before butyl vinyl ether (1 mL) was added to quench the catalyst. Solvent was removed under 
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reduced pressure. The solid residue was dissolved in DCM, precipitated in 14 ml of hexane:ether 
mixture (v:v = 30:1) and centrifuged for 3 times. The precipitate was dried to give a brown 
transparent film.  
To a solution of the above polymer (23 mg) in a mixture of DCM (5 mL) and nitrobenzene 
(0.1 mL) was added triallyl-O-tris (0.1 mL). The solution was stirred at 40 °C overnight and 
concentrated down under reduced pressure. The viscous residue was dissolved in DCM, 
precipitated in 14 ml of Hex : ether mixture (v : v = 27 : 1), centrifuged and the supernatant was 
discarded. The process was repeated 3 times. The precipitate was dried to give a film.  
Typical procedure for pX-2 (X= C, B, F, P and R). 
To a solution of pX-1 (20 mg) in 500 mL of anhydrous DCM under nitrogen atmosphere was 
added 1st Generation Grubbs catalyst (12 mg) in 1 mL of DCM. The mixture was stirred at  
35 °C for a total of 48 h. To the solution was added the catalyst portionwise (6 mg in 1 mL of 
DCM at the time point of 6 h and 3 mg at 30 h). The reaction was quenched by adding 15 mL of 
butyl vinyl ether, stirred for 30 min and concentrated under reduced pressure. The liquid residue 
was dissolved in DCM, precipitated in 14 mL of Hex : ether mixture (27:1), centrifuged and the 
supernatant was discarded. The process was repeated twice.  The crude was further purified by 
passing through a silica plug eluted by DCM. The solvent was removed using a rotary evaporator 
to afford a film.  
Typical procedure for pX (X= C, B, F, P and R). 
To a solution of pX-2 (20 mg) in a mixture of DCM (2 mL), acetone (2 mL) and water (1 mL) 
was added TFA (0.2 mL). The mixture was stirred at 40 °C for 2 h and concentrated using a 
rotary evaporator. The crude was dialyzed against 4 L of K2CO3 aqueous solution (w 0.05%) for 
6 h and 4 L of water for 6 h twice. The solution was lyophilized to afford foam-like solid.  
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Chapter 4 
Photoresponsive Molecular Switch for  
Regulating Transmembrane Proton-Transfer Kinetics 
 
Part of this chapter is adapted from the following publications: 
Ying Li, Edmund C. M. Tse, Christopher J. Barile, Andrew A. Gewirth and Steven C. 
Zimmerman*, Photoresponsive Molecular Switch for Regulating Transmembrane Proton-
Transfer Kinetics, J. Am. Chem. Soc. 2015, 137, 14059 - 14062. 
    
Christopher J. Barile, Edmund C. M. Tse, Ying Li, Thomas B. Sobyra, Steven C. 
Zimmerman, Ali Hosseini, and Andrew A. Gewirth*, Proton Switch for Modulating 
Oxygen Reduction by a Copper Electrocatalyst Embedded in a Hybrid Bilayer 
Membrane, Nat. Mater. 2014, 13, 619 - 623. 
	  
Collaboration and contribution statement:  
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4.1 Introduction  
Precisely regulated proton transfer is essential to many biological reactions and 
alternative energy schemes that involve redox reactions with one or more proton-coupled 
electron transfer (PCET) steps.1-4 As one example, the oxygen reduction reaction to form 
water (ORR: O2 + 4e– + 4H+ → 2H2O) is critical to sustaining life on Earth.5-6 
Cytochrome c oxidase (CcO) and laccase are two enzymes that evolved to develop 
intricate proton transport chains which provide exquisite control over the kinetics of 
proton delivery to the ORR active site.7-11 
The mechanisms associated with multi-step PCET reactions are difficult to decipher 
because of the convoluted interplay between the thermodynamics and kinetics of electron 
and proton transfer.2-4, 12 The use of a self-assembled monolayer (SAM) can decouple the 
kinetics and thermodynamics of electron transfer, the latter dictated by the electrode 
potential.13-14 We recently developed a new experimental framework using a hybrid 
bilayer membrane (HBM) to delineate the relative importance of the kinetics and 
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thermodynamics of proton transfer to a system that catalyzes PCET reactions.15-16 A 
HBM consisted of a SAM with a monolayer of lipid appended on top.17 In detail, a 
dinuclear Cu molecular ORR catalyst (CuBTT: Cu complex of 6-((3-(benzylamino)-
1,2,4-triazol-5-yl)amino)hexane-1-thiol) formed the SAM.16 We previously demonstrated 
that the spontaneous flip-flop diffusion of lipid-bound aliphatic acids functioned as a pH-
sensitive switch turning on and off transmembrane proton delivery to the catalyst.15 The 
proton delivery via this flip-flop diffusion of the proton carriers occurred spontaneously 
in the presence of a pH gradient.18-19 It could be advantageous to regulate the proton 
transfer kinetics more precisely without the associated perturbation in proton 
thermodynamics that arises with a pH change. 
To avoid concomitant changes in proton thermodynamics while modulating the 
proton kinetics, natural systems utilize light to execute an additional level of control over 
proton and electron transfer steps by having specific functional groups that adopt precise 
photo-induced conformational changes. For example, a 5-Å movement of an ubiquinone 
moiety accompanied by a 180° propeller twist of an isoprene chain upon illumination in 
the photosynthetic reaction center of Rhodobacter sphaeroides is a necessary prerequisite 
to proton uptake for photosynthesis that involves PCET steps.20 The intricate photo-
regulation of proton transport in nature has inspired a tremendous amount of effort 
towards mimicking these natural systems on the macromolecular level.21 Although 
artificial photosynthetic reaction centers have been developed in the past decades,22-23 the 
photo-regulation of transmembrane proton kinetics without involving electron transfer or 
proton thermodynamics fluctuation, to the best of our knowledge, has not been achieved 
with a single-component small molecular system. 
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A HBM with a photo-responsive proton carrier could mimic the light-induced 
conformational gating found in nature and afford a new approach to tune transmembrane 
proton transfer kinetics with temporal and spatial control. Furthermore, such a system 
could eliminate the need for chemical inputs that invariably generates waste products. In 
this report, we developed a simple, artificial, membrane-bound, photo-responsive proton 
carrier that regulated proton kinetics across a lipid membrane. The new proton carrier 
(BA) featured a boronic acid head-group for proton transfer, a stiff stilbene body for 
photo-responsiveness, and an alkyl tail for lipid incorporation. Boronic acids typically 
exhibit pKa values of ca. 9,24 a feature that ensures the proton carrier to be mostly in the 
neutral form in pH 7 solution. The ability of BA to cycle between two photo-
distinguishable states allowed us to construct a proof-of-concept, light-addressable 
transmembrane proton kinetics regulator in a HBM platform without perturbing the 
proton thermodynamics in the bulk solution.  
Like many other photo-responsive chromophores,25-26 a stiff stilbene moiety (1,1′-
biindane) has either a Z or E configuration with respect to its central double bond upon 
photoisomerization.27-29 This chromophore has garnered increasing attention because of 
its scalable synthesis, easy derivatization, lack of thermal relaxation at room temperature, 
high quantum yield (50%) for E to Z photoisomerization, and quantitative Z to E 
reversion.27-32 The stiff stilbene moiety has been applied as a light driven internal 
molecular force probe.31-32 Nevertheless, the proton gating ability of functional materials 
based on stiff stilbene remains largely unexplored. 
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4.2 Synthesis of the Proton Carrier (BA) and the Copper Catalyst Ligand 
We first prepared both the Z- and E-isomers of the protected photo-responsive switch, 
the synthesis beginning from the photoreactive core, followed by the sequential 
installation of the alkyl tail and the protected acid head-group (Scheme 4.1). The trivalent 
N-methyliminodiacetic acid (MIDA) ligand, developed by Burke and coworkers,33-34 was 
used to avoid decomposition of the boronic acid group during the synthesis. Indeed, the 
MIDA boronate ester was simply prepared from commercially available starting 
materials, survived the harsh reaction conditions, and allowed purification by 
chromatography. The deprotection of Z-1 and E-1 was easily achieved at room 
temperature with concentrated aqueous NaOH solution to afford the two isomers Z-BA 
and E-BA, respectively. 
Scheme 4.1 Preparation of the protected photoswitch molecules: Z-1 and E-1. 
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Our reported synthetic procedure for the copper catalyst ligand BTT included two 
low-yielding reductive amination reactions and required three nontrivial chromatographic 
purifications (Scheme 4.2).15 The new procedure for BTT preparation afforded a 
significant 13-fold improvement in the overall yield. Although five instead of four 
synthetic steps were needed, the new scheme eliminated one reductive amination step and 
one tedious chromatographic separation step (Scheme 4.3). Partial aminolysis of dimethyl 
N-cyanodithio-carbonimidate with benzylamine first gave 1 (N-substituted N’-cyano-S-
methylisothioureas), a key intermediate that readily cyclizes with hydrazine to afford 2, 
which could be easily purified by filteration.35 Reductive amination between the primary 
amine of 2 and the appropriate alkyl aldehyde was performed with NaBH3CN as the 
reducing agent in a one-pot reaction to prepare BTT on a large scale.  
Scheme 4.2 Original preparation of BTT 
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Scheme 4.3 Improved synthesis of BTT 
 
4.3 Photochemistry Studies of the BA in Solution 
The light-induced E-Z isomerization of BA was first demonstrated in solution ([BA] 
= 2 mg/mL) and followed by 1H NMR spectroscopy. For the interconversion experiments 
monitored using NMR techniques, the irradiation times for the E-to-Z and Z-to-E 
conversions were 40 and 30 min, respectively. Figure 4.1a displayed the structures of E-
BA and Z-BA, and highlighted the protons whose resonances were followed in the 1H 
NMR study. Figure 4.1b showed an overlay of truncated 1H NMR spectra: Z-BA, E-BA 
and one cycle of the E-Z-E conversion. The protons Ha and Hb in Z-BA (Figure 4.1b, 
black line) appeared at 2.88 and 2.79 ppm, respectively. Their equivalent protons Ha’ and 
Hb’ in E-BA (red line) shifted downfield to 3.15 ppm (Δδ [Ha] = 0.27 ppm) and 3.05 ppm 
(Δδ [Hb] = 0.26 ppm), correspondingly. Upon UV irradiation at 360 nm, about 40% of E-
BA was converted into Z-BA according to the 1H NMR integration (green line). The 
mixture was exposed to UV irradiation at 390 nm and the Z-isomer was almost 
quantitatively converted back to the E-isomer (blue line). The complete Z- to E- and 
partial E- to Z-stilbene photoisomerization is consistent with reported systems.27-28 The 
full isomerization cycle was repeated two more times, and similar results were obtained. 
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Figure 4.1c showed the percentage of E-BA versus the total BA plotted across	  sequential 
photoirradiation events. Despite these observable changes in the 1H NMR spectra, no 
significant changes were notable in the 11B NMR spectra (Figure 4.2), suggesting that the 
boronic-acid group remained intact. 
 
Figure 4.1 a) Structures of E-BA and Z-BA with the protons of interest labeled; b) 
stacked truncated NMR spectra of BA (Z- and E-isomers) in CD2Cl2, indicating the 
corresponding proton signal shifts according to the irradiation cycles. * = 1H resonance of 
the methyl group from MIDA after the deprotection step; c) the percentage of E-BA 
relative to the total BA amount changed upon irradiation at 360 nm and 390 nm.  
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Figure 4.2 (a) 11B-NMR of BA before irradiation; (b) 11B-NMR of BA after multiple 
cycles of irradiation. 
4.4 Photoelectrochemistry Studies of the BA in HBM 
Having demonstrated in solution the reversible photoresponsiveness of E-BA and Z-
BA, we probed their ability to act as proton carriers in a HBM electrochemically. 
Preparation of the general HBM system was reported elsewhere.15, 36 In short, BTT was 
deprotected and deposited as a SAM on a Au working electrode. Cu ions were 
incorporated into the BTT-modified Au surface using an ethanolic solution of Cu(ClO4)2, 
which was then covered with a monolayer of pure 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) or DMPC with 0.5 equivalent of proton carriers (Z-BA or E-BA) 
relative to DMPC. The lipid-forming solution is prepared following a modified published 
protocol.16-17 The deprotection of Z-1 or E-1 was performed by dissolving Z-1 or E-1 (3 
mg, 5.4 mol) in THF (0.2 mL). NaOH (0.01 mL, 10 M) was added, and the resulting 
solution was stirred vigorously for 15 min at room temperature. NH4Cl (9 mL, saturated 
aqueous) was added, and the mixture was stirred vigorously for 5 min. Ether (9 mL × 3) 
was added to extract the organic layer, which was then combined, dried, and concentrated 
using a rotary evaporator to about 0.1 mL. DMPC (7.3 mg, 10.8 µmol) in EtOH (2 mL) 
(a) (b) 
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was added to the ether solution containing Z-BA or E-BA. The organic solution was dried 
under a stream of Ar, resulting in a thin translucent film of DMPC mixed with Z-BA or 
E-BA at the bottom of a 20 mL glass scintillation vial. The vial was kept in a vacuum 
desiccator for 30 min. The film was reconstituted with EtOH (168 µL) and pH 7 
potassium phosphate buffer (10.5 mL, 100 mM) was added dropwise with gentle swirling. 
The resulting translucent lipid forming solution was then sonicated for 30 min and used 
without further purification. All procedures involving Z-BA or E-BA were conducted in 
the dark with all glassware wrapped with aluminum foil. 
Figure 4.3a displayed the architecture of the three HBMs with and without BA 
incorporated in the lipid layer. Figure 4.3b showed linear sweep voltammograms (LSVs) 
of O2 reduction by a SAM of CuBTT covered by a DMPC monolayer with and without 
the proton carriers added. In the absence of the proton carriers, the lipid layer blocked the 
access of protons in bulk solution to CuBTT inside a HBM, resulting in a background O2 
reduction current density of about 40 µA cm-2 at -450 mV vs. Ag/AgCl (Figure 4.3b, 
black line). 
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Figure 4.3 (a) Schematic of the HBMs studied: (i) DMPC only, (ii) DMPC with Z-BA 
incorporated, and (iii) DMPC with E-BA incorporated. (b) Linear sweep voltammograms 
(LSVs) of O2 reduction catalyzed by CuBTT covered by a monolayer of DMPC (black) 
with Z-BA (blue) or E-BA (red) incorporated in the lipid layer in O2-saturated pH 7 
buffer at 10 mV/s. 
Upon incorporating Z-BA, the O2 reduction current density at -450 mV increased by 
about 60% (Figure 4.3b, blue line), indicating that Z-BA delivers protons from bulk 
solution across the lipid layer to the CuBTT catalyst for O2 reduction as demonstrated 
previously for other proton carriers in HBM systems.15-16 However, the O2 reduction 
current density with E-BA added to the lipid layer (Figure 4.3b, red line) was the same as 
the lipid-only case, signifying that E-BA was unable to transport protons across the 
hydrophobic lipid layer. The different behavior of E-BA and Z-BA was likely not a result 
of a change in pKa, because analogous carboxylic acids exhibit similar pKa values (Figure 
4.4). We propose the effect originates in the different lengths of the two isomers in the 
phospholipid. When the proton carrier isomerizes from E to Z, it decreases in length by 
~10 Å and reduces the van der Waals interactions between the proton carrier and the 
	  	   82	  
phospholipids.37-38 Thus, we suggest that, relative to the E-isomer, the Z-isomer has a 
lower energy barrier for transmembrane flip-flop diffusion and thus induces proton 
delivery. 
 
Figure 4.4 Structures of oleic acid and elaidic acid.  
We next explored the photo-switching behavior of E-BA and Z-BA in a HBM. Figure 
4.5a displayed a set of LSVs of O2 reduction by CuBTT covered by a DMPC monolayer 
with Z-BA added to the lipid layer with various irradiation periods. Upon irradiation with 
390 nm for 1 and 5 min, the O2 reduction current density at -450 mV dropped by about 
60% and 95%, respectively (Figure 4.5a, red and blue lines). As the irradiation time 
increased, the O2 reduction current decreased until it reached nearly the same value as the 
lipid-only case or the case with E-BA added to the DMPC layer. These findings indicated 
that as more of the proton carrier was converted to its inactive form (E-BA), fewer 
protons were delivered across the lipid membrane, thus resulting in less catalytic O2 
reduction current. 
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Figure 4.5 (a) O2 reduction LSVs in O2-saturated pH 7 phosphate buffer at a scan rate of 
10 mV/s by CuBTT covered by a monolayer of DMPC with Z-BA incorporated in the 
lipid layer irradiated with 390 nm light for 0 min (black), 1 min (red), and 5 min (blue), 
and (b) E-BA incorporated in the lipid layer irradiated with 360 nm light for 0 s (black), 
10 s (red), and 60 s (blue). 
Figure 4.5b showed O2 reduction LSVs by CuBTT covered by a DMPC monolayer 
with E-BA added to the lipid layer with various irradiation periods. Upon irradiation with 
360 nm for 10 s, the O2 reduction current density increased by about 65% (Figure 4.5b, 
red line). The O2 reduction current reached a value similar to the case with Z-BA added to 
the DMPC layer by irradiating for 1 min (Figure 4.5b, blue line). Although the solution 
studies (Figure 4.1) indicated that E-to-Z isomerization was non-quantitative, the results 
shown here suggested that a sufficient amount of Z-isomer was generated in the lipid 
layer to achieve saturation in the transmembrane proton flux. We noted that the E-to-Z 
switching time is shorter than the Z-to-E switching time, an observation consistent with 
the isomerization kinetics of other stiff stilbenes.39 Control experiments demonstrated 
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that the integrity of the CuBTT SAM and the lipid layer was not compromised by 
irradiating with light at 360 and 390 nm (Figure 4.6).  
 
Figure 4.6a Linear sweep voltammograms (LSVs) of O2 reduction catalyzed by CuBTT 
(black) irradiated with 360 nm light for 15 min (red) or 390 nm light for 15 min (blue) in 
O2-saturated pH 7 phosphate buffer at a scan rate of 10 mV/s.  
The black line of Figure 4.6a showed the LSV of CuBTT in O2-saturated solution. 
The current density observed was similar to those observed previously,15 suggesting that 
the new synthetic route of BTT does not perturb the O2 reduction activity of CuBTT. 
The red and blue lines of Figure 4.6a showed the LSVs of CuBTT in O2-saturated 
solution after irradiating for 15 min with 360 nm and 390 nm light, respectively. These 
results demonstrated that both the Au-thiol linkage and the CuBTT complex were stable 
upon exposing to 360 nm or 390 nm light for 15 min. 
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Figure 4.6b LSVs of O2 reduction catalyzed by CuBTT covered by a monolayer of 
DMPC (black) irradiated with 360 nm light for 15 min (red) or 390 nm light for 15 min 
(blue) in O2-saturated pH 7 phosphate buffer at a scan rate of 10 mV/s.  
Figure 4.6b displayed the LSVs of CuBTT covered by a monolayer of DMPC in O2-
saturated solution with and without irradiation. The current densities observed in all three 
cases were comparable, indicating that the integrity of the lipid layer was not perturbed 
by exposing to 360 nm or 390 nm light for 15 min. To further probe the integrity of the 
lipid layer, we subjected the surfaces to a blocking experiment as shown in Figure 4.6c. 
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Figure 4.6c Representative cyclic voltammograms (CVs) of a SAM of CuBTT (black 
dashed line) and the HBMs containing CuBTT (solid lines) with E-BA incorporated in 
the lipid layer after irradiation with 360 nm light (blue) then with 390 nm light (green) 
and Z-BA incorporated in the lipid layer after irradiation with 390 nm light (red) then 360 
nm light (orange) in a solution of K3Fe(CN)6 (1 mM) with KCl (100 mM) at a scan rate 
of 50 mV/s. 
To confirm that the integrity of the lipid layer was not perturbed by the 
photoisomerization process, “blocking” experiments were conducted after irradiation in 
an aqueous KCl (100 mM) solution containing K3Fe(CN)6 (1 mM) with Z- and E-BA 
incorporated in the lipid layer of the HBMs. In all cases presented in Figure 4.6c, the 
absence of the Fe(II)/Fe(III) wave indicated that a well-formed lipid layer was present 
after irradiation and O2 reduction.  
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Figure 4.6d LSVs of O2 reduction catalyzed by CuBTT covered by a monolayer of 
DMPC with Z-BA (black dashed line), E-BA (red dashed line), E-BA irradiated with 360 
nm light for 5 min (black solid line), E-BA irradiated with 360 nm light for 10 min (red 
solid line), Z-BA irradiated with 390 nm light for 10 min (blue solid line), and Z-BA 
irradiated with 390 nm light for 15 min (blue solid line) in O2-saturated pH 7 phosphate 
buffer at a scan rate of 10 mV/s.  
Figure 4.6d shows the LSVs of CuBTT covered by a monolayer of DMPC with light-
responsive proton carriers in O2-saturated solution. Upon irradiating E-BA with 360 nm 
light for 5 and 10 min, the current densities observed are lower than the “enhanced” state. 
Furthermore, upon irradiating Z-BA with 390 nm light for 15 min, the current density 
observed was similar to the “unenhanced” state. The observed degradation after 
prolonged exposure to light could result from the proton carriers leaching from the lipid 
layer or being damaged by light. 
We further examined light-induced proton delivery in a HBM after a complete on-off-
on cycle. Figure 4.7 displayed LSVs of O2 reduction by CuBTT covered by a DMPC 
monolayer with Z-BA incorporated after sequential irradiation. Upon irradiation with 390 
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nm light for 5 min and then 360 nm light for 1 min, the O2 reduction current density was 
revived to within 10% of the current density of the initial on-state (Figure 4.7, blue line), 
testifying to the reversibility of the system. Taken together, these results represented the 
first example of using a molecular switch and light to gate proton delivery across a 
phospholipid membrane.  
 
Figure 4.7 O2 reduction LSVs in O2-saturated pH 7 phosphate buffer at a scan rate of 10 
mV/s by CuBTT covered by a monolayer of DMPC with Z-BA incorporated in the lipid 
layer (black) irradiated with 390 nm light for 5 min (red) followed by 360 nm light for 1 
min (blue). 
Furthermore, we interrogated the content of the lipid layer before and after the 
photoelectrochemical experiments using ESI-MS and 1H NMR. After illumination at 390 
nm for 5 min and then 360 nm for 1 min, the lipid layers were extracted by washing the 
lipid layer with EtOH three times. EtOH was removed under reduced pressure and 
reconstituted in CD2Cl2 for the characterizations. ESI-LRMS data indicated the presence 
of the proton carriers (Figure 4.8). 1H NMR spectra demonstrate that the slight decrease 
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in O2 reduction current density could stem from leaching of the proton carrier from the 
lipid layer of the HBM into bulk solution (Figure 4.9).  
 
 
Figure 4.8 ESI-LRMS of extracted lipid layer of HBM with (a) E-BA [M+Cl]− (calcd 
483.5, found 483.2) and (b) Z-BA [M−H]− (calcd 447.5, found 447.3) incorporated in the 
lipid layer.  
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Figure 4.9a 1H-NMR spectra of extracted lipid layer of HBM with the photoswitch 
incorporated in the lipid layer before the on-off-on experiment. Gray = 1H-NMR raw data, 
black = cumulative peak fit, red = peak fit for DMPC, blue = peak fit for E-BA, and 
green = peak fit for Z-BA. 
 
Figure 4.9b 1H-NMR spectra of extracted lipid layer of HBM with the photoswitch 
incorporated in the lipid layer after the on-off-on experiment. Gray = 1H-NMR raw data, 
black = cumulative peak fit, red = peak fit for DMPC, blue = peak fit for E-BA, green = 
peak fit for Z-BA, and purple = peak fit for degradation product. 
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Figure 4.10 LSVs of O2 reduction catalyzed by CuBTT covered by a monolayer of 
DMPC with Z-BA (black dashed line), E-BA (red dashed line), Z-BA irradiated with 390 
nm light for 5 min followed by 360 nm light for 10 s (red solid line), Z-BA irradiated 
with 390 nm light for 5 min followed by 360 nm light for 5 min (blue solid line), Z-BA 
irradiated with 390 nm light for 10 min followed by 360 nm light for 1 min (green solid 
line), Z-BA irradiated with 390 nm light for 10 min followed by 360 nm light for 5 min 
(black solid line), and Z-BA irradiated with 390 nm light for 10 min followed by 360 nm 
light for 10 min (orange solid line) in O2-saturated pH 7 phosphate buffer at a scan rate of 
10 mV/s.  
Similar to the results obtained in Figure 4.6d, Figure 4.10 showed that prolonged 
exposure to 360 nm and 390 nm irradiation caused irreversible decrease in O2 reduction 
current. Figure 4.10 red line showed that 10 s is not enough to convert all the E-BA (the 
inactive form) into Z-BA (the active form), similar to the red line shown in Figure 4.5b. 
Figure 4.10 blue line indicated that 5 min exceeded the irradiation time limit and resulted 
in lowered O2 reduction current, similar to the black line shown in Figure 4.6d. The green, 
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orange, and black lines in Figure 4.10 together demonstrated that in the event of 
irradiation with 390 nm light for 10 min, subsequent irradiation with 360 nm light could 
not fully recover the O2 reduction current to the reference “enhanced” state, regardless of 
the length of irradiation with 360 nm light. This result was likely caused by the 
irreversible leaching of the proton carrier from the lipid layer during irradiation - an 
amplification of 10% dissolution of proton carrier in the on-off-on case shown in Figure 
4.7.  
4.5 Conclusions 
In summary, we have developed the first photoresponsive proton gate in a HBM and 
demonstrated its application by successively turning off and back on proton transfer for 
use in a PCET reaction without concomitant changes in solution pH. The photoswitch 
uses the interconversion of the Z- or E-isomer, which allows a flipping mechanism that, 
in turn, facilitates transmembrane proton delivery.  This matching of molecular to lipid 
structure by modulating proton flux directly leads to the on- and off-switching of the 
lipid-covered O2 reduction catalyst. We envision that by delineating the effects of proton 
transfer thermodynamics and kinetics, we can further elucidate the reaction mechanism of 
PCET processes. Further spatial regulation of this photoresponsive proton gate in the bio-
inspired HBM platform could permit the development of more complex hybrid models 
for future biophotonics, optoelectronics, molecular switches, and memory elements. 
4.6 Experimental 
4.6.1 General Methods 
 The general instrument setup was described in Section 2.6. 
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4.6.2 Materials 
All optical apparatuses including mounted LEDs (M385L2 and M365L2, max current 
limit = 700 mA), power source drivers (DC2100), collimators (COP1-A), adaptors 
(SM1A2), couplers (SM2T2), and band pass filters (390 nm and 360 nm, FWHM = 10 
nm) were purchased from Thorlabs, Inc. 
4.6.3 Synthetic Procedures 
 
Compound 2. To a solution of (4-bromobutyl)boronic acid (540 mg, 3 mmol) in 30 mL 
of benzene and 3 mL of DMSO was added methyliminodiacetic acid (441.4 mg, 3 mmol). 
The suspension was refluxed for 3 h and became a clear solution. The solvents were 
removed using a rotary evaporator and the residue was dissolved in about 50 mL of 
EtOAc. The organic layer was washed with about 50 mL of brine, dried over Na2SO4, and 
concentrated to a solution of about 5 mL using a rotary evaporator. The solution was 
dropwise added into 50 mL of ether. The precipitation was collected by vacuum filtration 
to afford 720 mg (82%) of the product as a white solid. 1H NMR (CD3OD : CDCl3 = 1 : 9) 
δ 3.83 (d, J = 16.5, 2H), 3.69 (d, J = 16.5, 2H), 2.93 (s, 3H), 1.92 (m, 2H), 1.55 (m, 4H), 
0.65 (m, 2H). ESI-LRMS (m/z): calcd for [M+H]+, 292.0; found, 291.9. 
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Compound 4. To a solution of 3 (600 mg, 1.5 mmol) in 10 mL of DCM and 5 mL of 
MeOH was added NaOMe (1 g, 19 mmol). The suspension immediately turned red and 
was stirred at room temperature for 1 h. Prolonged stirring resulted in the formation of 
side products. The mixture was filtered, and the solvent was removed using a rotary 
evaporator. The residue was dissolved in DCM and dried over Na2SO4. The organic layer 
was concentrated using a rotary evaporator to give 320 mg (78%) of the product as an 
off-red waxy solid. The solid was used without further purification. 1H NMR δ 7.63 (s, 
2H), 7.14 (m, 2H), 6.70 (m, 2H), 2.90 (m, 4H), 2.81 (m, 4H). ESI-LRMS (m/z): calcd for 
[M+H]+, 265.1; found, 265.2. 
Compound 5. To a solution of 4 (300 mg, 1.1 mmol) and 1-bromohexane (168 mg, 1.0 
mmol) in 6 mL of dry ACN was added K2CO3 (800 mg, 5.9 mmol). The mixture was 
stirred at 80 °C overnight. The suspension was filtered, and the filtrate was concentrated 
using a rotary evaporator. The residue was dissolved in DCM and dried over Na2SO4. 
The solvent was removed using a rotary evaporator, and the crude product was purified 
by gradient column chromatography (EtOAc : Hex = 0 : 1 to 1 : 9) to give 152 mg (45%) 
of the product as a yellow waxy solid. 1H NMR δ 7.61 (m, 2H), 7.16 (m, 2H), 6.75 (m, 
1H), 6.67 (m, 1H), 4.76 (s, 1H), 3.92 (t, J = 6.5, 2H), 2.91 (m, 4H), 2.80 (m, 4H), 1.76 (m, 
2H), 1.43 (m, 2H), 1.32 (m, 4H), 0.89 (m, 3H). ESI-LRMS (m/z): calcd for [M+H]+, 
349.2; found, 349.1. 
Compound Z-1. To a solution of 5 (75 mg, 0.22 mmol) and 2 (75 mg, 0.26 mmol) in 3 
mL of dry ACN was added K2CO3 (300 mg, 2.2 mmol). The mixture was stirred at 80 °C 
overnight. The suspension was filtered, and the filtrate was concentrated down under 
vacuum. The residue was dissolved in DCM and dried over Na2SO4. The solvent was 
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removed under vacuum, and the crude product was purified by gradient column 
chromatography (EtOAc : Hex = 0 : 1 to 1 : 4) to give 58 mg (48%) of the product as a 
yellow gel-like solid. 1H NMR δ 7.62 (m, 2H), 7.17 (m, 2H), 6.74 (m, 2H), 3.92 (m, 4H), 
3.79 (m, 2H), 3.64 (m, 2H), 2.91 (m, 4H), 2.84 (s, 3H), 2.81 (m, 4H), 1.80 (m, 2H), 1.73 
(m, 2H), 1.53 (m, 2H), 1.42 (m, 2H), 1.31 (m, 4H), 0.88 (m, 4H), 0.65 (m, 2H). 13C NMR 
(CD3OD:CDCl3=1:9) δ 166.8, 157.5, 141.7(1), 140.7(0), 140.6(6), 135.6, 135.5, 125.7, 
125.7, 115.0, 114.9, 109.3, 109.1, 68.5, 67.9, 62.7, 62.1, 53.6, 45.7, 35.5(3), 35.5(2), 32.1, 
31.7, 30.0, 29.9(9), 29.5, 25.9, 22.8, 20.5, 14.2. 11B NMR δ 13.0. ESI-HRMS (m/z): calcd 
for [M+H]+ 560.3183; found, 560.3203. 
 
Compound 6. To a suspension of 6-hydroxy-1-indanone (1.6g, 11 mmol) and DMAP 
(0.25 g, 2 mmol) in 10 mL of DMF was added glacial acetic acid (0.7 g, 12 mmol). The 
mixture was stirred at room temperature for 15 min and EDC was added (2.5 g, 13 mmol). 
The mixture was stirred overnight at room temperature, and the solvent was removed 
under vacuum. The residue was dissolved in DCM and washed with brine. The organic 
layer was dried over Na2SO4 and concentrated using a rotary evaporator. The crude 
product was purified by gradient column chromatography (EtOAc : Hex = 0 : 1 to 1 : 2) 
	  	   96	  
to give 1.2 g (58%) of the product as an off-white solid. 1H NMR δ 7.49 (d, J = 10.5, 1H), 
7.45 (d, J = 3, 1H), 7.31 (dd, J = 10, 3, 1H), 3.14 (m, 2H), 2.74 (m, 2H), 2.83 (s, 3H).  
Compound 7. A 200 mL flask was charged with Zn powder (3.86 g, 60 mmol), flame-
dried under vacuum, and cooled under N2. The flask was charged with 90 mL of dried 
THF and cooled to -78 °C. TiCl4 in THF (1 M, 3.3 mL, 3.3 mmol) was added dropwise, 
and the suspension was warmed up to room temperature and refluxed for 1 h. A solution 
of 6 (1.2 g, 6.3 mmol) in 5 mL of THF was added, and the mixture was refluxed for 3 h. 
The reaction was cooled to room temperature and quenched with 90 mL of saturated 
NH4Cl solution. The mixture was stirred at room temperature for 4 h and left to sit for 1 h. 
The top organic layer was separated and concentrated using a rotary evaporator. The 
residue was dissolved in DCM, dried over Na2SO4, and concentrated using a rotary 
evaporator to afford 850 mg (77%) of the crude product as a light pink solid. The solid 
was used without further purification. ESI-LRMS (m/z): calcd for [M+H]+, 349.1; found, 
349.2, 307.2 [M+H-Ac]+, 265.2 [M+H-2Ac]+.  
Compound 8. To a solution of 7 (850 mg, 2.4 mmol) in 3 mL of DCM and 1 mL of 
EtOH was added 4 mL of NaOH (10 M) solution. The mixture was stirred at 80 °C for 3 
h. The volatile solvents were removed using a rotary evaporator, and the residue was 
dissolved in DCM. The organic layer was washed with saturated NH4Cl solution, dried 
over Na2SO4, and concentrated using a rotary evaporator to give 630 mg (96%) of the 
crude product as an off-white solid. The solid contained both cis and trans forms and was 
used without further purification.  
Compound 9. To a solution of 8 (180 mg, 0.68 mmol) and 1-bromohexane (100 mg, 0.62 
mmol) in 4 mL of dry DMF was added K2CO3 (125 mg, 1.2 mmol). The mixture was 
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stirred at 80 °C overnight. The suspension was filtered, and the filtrate was concentrated 
using a rotary evaporator. The residue was dissolved in DCM and dried over Na2SO4. 
The solvent was removed using a rotary evaporator, and the crude product was purified 
by gradient column chromatography (EtOAc : Hex = 0:1 to 1:9) to give 112 mg (55%) of 
the product as an off-white solid. 1H NMR (CD3OD : CDCl3 = 1 : 9) δ 7.35 (d, J = 8.5, 
2H), 7.32 (d, J = 2, 2H), 7.315 (d, J = 7.5, 2H), 7.29 (d, J = 2, 2H), 6.94 (d, J = 2.5, 2H), 
6.93 (d, J  = 2, 2H), 6.89 (d, J = 2.5, 2H), 6.87 (d, J = 2.5, 2H), 4.33 (b, 1H), 4.16 (d, J = 
6.5, 2H), 3.31 (m, 2H), 3.19 (m, 2H), 1.97 (m, 2H), 1.65 (m, 2H), 1.52 (m, 4H), 1.08 (m, 
3H). ESI-LRMS (m/z): calcd for [M+H]+, 349.2; found, 349.7. 
Compound E-1. To a solution of 9 (83.8 mg, 0.24 mmol) and 2 (138.4 mg, 0.48 mmol) 
in 3 mL of dry DMF was added K2CO3 (47.5 mg, 4.8 mmol). The mixture was stirred at 
80 °C overnight. The suspension was filtered, and the filtrate was concentrated using a 
rotary evaporator. The residue was dissolved in DCM and dried over Na2SO4. The 
solvent was removed using a rotary evaporator, and the crude product was purified by 
gradient column chromatography (EtOAc : Hex = 0 : 1 to 1 : 4) to give 73 mg (54%) of 
the product as an off-white solid. 1H NMR (CD3OD : CDCl3 = 1 : 9) δ 7.16 (m, 2H), 7.12 
(s, 2H), 6.73 (m, 2H), 3.97 (t, J = 6, 2H), 3.97 (t, J = 6.5, 2H), 3.95 (d, J = 17, 2H), 3.75 
(d, J = 17, 2H), 3.14 (m, 4H), 3.01 (m, 4H), 2.87 (s, 3H), 1.87-1.71 (m, 4H), 1.59-1.39 (m, 
4H), 1.31 (m, 4H), 0.87 (m, 3H), 0.66 (m, 2H). 13C NMR (CD3OD : CDCl3 = 1 : 9) δ 
158.1, 144.4, 139.5, 135.8, 125.3, 113.7, 111.0, 68.6, 68.2, 61.9, 45.6, 32.5(4), 
32.5(2),32.3, 31.7, 30.259, 30.254, 29.4, 25.8, 22.7, 20.6, 14.0. 11B NMR δ 13.0. ESI-
HRMS (m/z): calcd for [M+H]+, 560.3183; found, 560.3182. 
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Compound 10. was prepared using a literature procedure.40 Trityl chloride (2.78 g, 10 
mmol) in DCM (50 mL) was added dropwise to a stirred solution of 6-mercapto-hexan-1-
ol (2 mL, 15 mmol) in DCM (20 mL) over 30 min at room temperature. The mixture was 
stirred for 30 min and washed with an aqueous solution of NaOH (0.1 M). The organic 
layer was dried over anhydrous Na2SO4, gravity filtered, and concentrated using a rotary 
evaporator. Flash chromatography with a step gradient (EtOAc : Hex = 1 : 9 to 1 : 3) 
afforded 3.2 g (85%) of  the product as a white solid. 1H NMR δ 7.45-7.15(m, 15H), 3.58 
(t, J = 6.6, 2H), 2.15 (t, J = 7.3, 2H), 1.48 (m, 2H), 1.40 (m, 2H), 1.26 (m, 5H). ESI-
LRMS (m/z): calcd for [M+H]+ 377.2; found 377.2. 
Compound 11. was prepared according to a previously reported procedure for a similar 
compound.41 A solution of oxalyl chloride (350 mg, 2.8 mmol) in DCM (6 mL) was 
cooled to –78 °C. A mixture of DMSO (430 mg, 5.5 mmol) and DCM (2.5 mL) was 
added dropwise. The resulting mixture was stirred for 5 min, and 10 (940 mg, 2.5 mmol) 
dissolved in DCM (1 mL) was added dropwise. The solution was stirred for 15 min, and 
TEA (1.27 g, 12.5 mmol) was added. The mixture was allowed to warm to room 
temperature and washed with an aqueous solution of HCl (1 M, 10 mL). The aqueous 
layer was extracted with DCM (3×10 mL), and the combined organic layers were washed 
with brine (20 mL), dried over anhydrous Na2SO4, gravity filtered, and concentrated 
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using a rotary evaporator to yield 908 mg (97%) of the product as a colorless oil. 1H 
NMR δ 9.71 (s, 1H), 7.45-7.15 (m, 15H), 2.34 (t, J = 7.5, 2H), 2.15 (t, J = 7.5, 2H), 1.49 
(m, 2H), 1.39 (m, 2H), 1.27 (m, 2H). ESI-LRMS (m/z): calcd for [M+H]+ 375.2; found 
375.2. 
Compound 12. A mixture of 11 (600 mg, 1.6 mmol) and 1,2,4-triazole-3,5-diamine (300 
mg, 3.3 mmol) in EtOH (10 mL) was stirred at room temperature for 5 h. Sodium 
borohydride (100 mg, 2.6 mmol) was added, and the resulting suspension was stirred for 
an 1 h at room temperature. The reaction was quenched by adding water (0.5 mL) and 
concentrated under vacuum to yield a white solid. The solid was dissolved in DCM (10 
mL) and washed with brine (2 × 10 mL). The combined organic layers were dried over 
anhydrous Na2SO4, gravity filtered, and concentrated using a rotary evaporator. Gravity 
chromatography with a step gradient (DCM : MeOH = 19 : 1 to 9 : 1) afforded 124 mg 
(17%) of the product as a white solid estimated by NMR to be ~90% pure. 1H NMR δ 
7.45-7.15 (m, 15H), 3.10 (t, J = 7.0, 2H), 2.13 (t, J = 7.0, 2H), 1.47 (m, 2H), 1.37 (m, 2H), 
1.22 (m, 4H). ESI-LRMS (m/z): calcd for [M+H]+ 458.2, found 458.2. 
Compound 13. A mixture of 12 (120 mg, 0.26 mmol) and benzaldehyde (60 mg, 0.57 
mmol) in 3:1 (v:v) EtOH:DCM (4 mL) was stirred at 40 °C for 12 h. Sodium borohydride 
(50 mg, 1.3 mmol) was then added, and the suspension was stirred for 1 h at room 
temperature. The reaction was quenched by adding water (0.3 mL) and concentrated 
under vacuum to yield a white solid. The solid was dissolved in DCM (10 mL) and 
washed with brine (2 × 10 mL). The organic layer was dried over anhydrous Na2SO4, 
gravity filtered, and concentrated using a rotary evaporator. Gravity chromatography with 
a step gradient (DCM : MeOH = 49 : 1 to 19 : 1) afforded 20 mg (14%) of the product as 
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a white solid. 1H NMR δ 7.45-7.15 (m, 20H), 4.67 (b, 1H), 4.37 (d, J = 5.5, 2H), 4.19 (b, 
1H), 3.07 (m, 3H), 2.12 (t, J = 7.5, 2H), 1.46 (m, 2H), 1.37 (m, 2H), 1.22 (m, 4H); 13C 
NMR: δ 145.2, 129.8, 128.9, 128.0, 127.7, 127.5, 126.8, 66.6, 47.7, 43.6, 32.1, 29.7, 28.7, 
26.6. ESI-HRMS (m/z): calcd for [M+H]+ 548.2848; found 548.2842. 
 
Compound 15. To a solution of dimethyl N-cyanodithiocarbonimidate (1.462 g, 10 
mmol) in 20 mL of ethanol was added benzylamine (1.092 mL, 10 mmol), and the 
mixture was refluxed overnight. To the resulting solution was added hydrazine 
monohydrate (1 g, 20 mmol) and the mixture was refluxed for 3 h. The mixture was 
concentrated using a rotary evaporator, triturated in 50 mL of DCM, and filtered to afford 
1.5 g of the product as a white crystal. The solid was used without further purification. 
Compound 13. To a solution of 6-(tritylthio)hexanal (748 mg, 2 mmol) and 15 (1 g, 5.3 
mmol) in 6 mL of DCM and 3 mL of MeOH at -78 °C was added sodium 
cyanoborohydride (500 mg, 8 mmol). The mixture was slowly warmed up to room 
temperature and stirred overnight. The crude product was diluted with 10 mL of DCM, 
washed with 10 mL of brine, dried over Na2SO4, and concentrated using a rotary 
evaporator. The crude product was purified by chromatography (EtOAc) to give 426.8 
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mg (39%) of the product as a white solid. NMR and mass spectrometry data are 
consistent with the same compound prepared above.  
4.6.4 Electrochemistry Preparation 
Potassium phosphate buffer solutions (pH 7) were prepared using Milli-Q water (> 18 
MΩ cm) and were sparged with Ar or O2 for 30 min prior to each experiment. 
Electrochemical studies were carried out using a CH Instruments 760 D Electrochemical 
Workstation (Austin, TX). A three-electrode cell was used with a carbon counter 
electrode. Electrochemical potentials were measured and reported with respect to a ‘no 
leak’ Ag/AgCl (3 M KCl, eDAQ, Inc.) reference electrode. Au working electrodes (0.22 
cm2) were deposited using an electron-beam vacuum deposition apparatus. A Ti adhesion 
layer (50 nm), followed by a Au layer (150 nm), was deposited on Pyrex glass slides. The 
electrodes were rinsed with water and EtOH prior to use. All photoelectrochemical 
experiments were conducted inside a Faraday cage in a dark room. 
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